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ABSTRACT 
 
Brain endothelial cell types are frequently used as in vitro models to study the 
blood-brain barrier (BBB). Oxidative stress (OS) has been reported numerous times 
to cause BBB dysfunction which is crucial to the initiation and or propagation of 
several neurologic disorders.  
Glutathione (GSH) plays a significant role in the defence against OS in the brain 
endothelial cells. Therefore, the brain endothelial cell line bEnd.5 was profiled as 
an endothelium model of the BBB because of its natural GSH content, and its 
reactive oxygen species (ROS)-neutralising capacity in the presence and/or absence 
of a modest concentration (25 µM) of a standard antioxidant, Trolox. Fluorescent 
microscopy with monochlorobimane (mBCl) as a fluorescent probe was used for 
cellular GSH targeting. Furthermore, the GSH GloTM assay kit (Promega) and the 
mBCl fluorescent probe were used for the fluorometric measurement of 
intracellular GSH content and hydrogen peroxide (H2O2) was added as a 
quantifiable source of ROS. The quantity of GSH depletion and changes in cellular 
morphology at varying concentrations of H2O2 were compared with untreated cells. 
mBCl fluorescence indicating the presence of GSH was demonstrated in bEnd5 
cells, and its intensity was variable among the cells which is suggestive of 
differences in individual cell redox status and viability. The cytoplasmic extensions 
of the cells showed the presence of GSH which underscores the dependence of its 
viability on the presence of GSH. Micrographs show that the nuclear membrane has 
a high localisation of GSH which could be indicative of the important role GSH 
plays in protecting Deoxyribonucleic acid (DNA) from OS. In a proliferation study, 
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bEnd5 cell growth was shown to increase after 24 hours; its doubling time increased 
from 15.66 hours within the first 24 hours to 11 hours within the second 24 hours. 
This is important for the accurate estimation of cellular GSH after 24 hours that is 
allowed for attachment in culture. The normal GSH content in a bEnd5 cell-line 
was extrapolated to be 0.031±0.00035 nmol.cell-1 and 0.00092±0.00021 nmol.cell-
1 for glutathione disulfide (GSSG). The basal thiol redox status GSH:GSSG ranged 
from 94:6 to 97:3 over an extended cell culture period of 24-96 hours. Cellular GSH 
content, with and without exogenous antioxidant, was well buffered and was 
neutralised at 50, 150, 250 and 500 µM H2O2 concentration. Cell growth up to this 
H2O2 concentration were comparable to controls but from 1 mM up to 2.5 mM 
H2O2 growth changes were observed, while the addition of the antioxidant Trolox 
allowed for the maintenance of normal cell growth to be extended up to 1 mM H2O2. 
De novo GSH synthesis was maximally initiated in a switch-like fashion at the 
slightest oxidative challenge. At the point of cellular growth compromise, 
approximately 30-35% of the total GSH remained unavailable for ROS 
neutralisation. In the study, we showed that bEnd5 cell line contains substantial 
amounts of GSH with the capability of neutralising a higher magnitude of ROS 
compared to several varieties of cells as shown in similar studies. Furthermore, 
factors that can facilitate the access to the latent GSH content of the cells will 
enhance cellular ROS-neutralising capacity. 
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CHAPTER ONE 
Literature review 
 
 
1.1 Glutathione 
1.1.1 Discovery of glutathione 
 
In 1888, glutathione (GSH) was discovered by de Rey Pailhade in yeast cells 
(Aoyama et al., 2008). He called GSH “philothione” (from the Greek words 
signifying “love” and “sulfur”) because of its ability to reduce sulphur to hydrogen 
sulphide (Aoyama & Nakaki, 2013). In 1924, F.G. Hopkins reported this substance 
as a dipeptide comprising cysteine acid and glutamate, which he called 
“glutathione”, but it is, in fact, a tripeptide, consisting of glutamate, cysteine, and 
glycine (Aoyama & Nakaki, 2013; Aoyama et al., 2008). In the 1930s its structure 
was identified and was later recognised as “the most important non-protein thiol” 
(Aoyama & Nakaki, 2013; Aoyama et al., 2008).  
GSH’s reaction to gluten in wheat was useful in weakening the strength of bread 
dough for baking. However, in living cells the significance of GSH function did not 
receive much attention until the 1970s, when a number of studies on GSH-related 
biochemical reactions and its metabolism emerged (Aoyama & Nakaki, 2013; 
Aoyama et al., 2008). Many studies on GSH have been published indicating its 
involvement in pivotal cellular physiological processes, e.g., antioxidant defence, 
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detoxication of xenobiotics, intracellular redox homeostasis, Cys carrier/storage, 
cell signalling, protein function, gene expression and cell 
differentiation/proliferation. GSH, L-γ-glutamyl-L-cysteinyl-glycine, is the 
predominant low-molecular-weight thiol compound present in almost all eukaryotic 
cells and is crucial to neutralise reactive oxygen species (ROS) molecules and to 
prevent cellular damage (Aoyama & Nakaki, 2013). 
 
1.1.2 Glutathione synthesis 
 
GSH is synthesised intracellularly from its amino acids in two consecutive steps by 
the consecutive action of two adenosine triphosphate (ATP)-dependent enzymes; 
γ-glutamylcysteine synthetase (γ-GCS, also known as a γ-glutamylcysteine ligase 
(γ-GCL) and glutathione synthetase (GS). Both enzymes are cytosolic. The first 
step in GSH syntheses is mediated by γ-GCS which utilise glutamate (Glu) and Cys 
as substrates forming the dipeptide γ-glutamylcysteine (γGluCys). 
                                                                                                               [Reaction 1] 
This reaction is the rate-limiting step in glutathione synthesis (Dringen, 2000; Li, 
et al. 2012). During the GCS reaction, the γ-carboxyl group of glutamate interacts 
with the amino group of Cys to form a peptidic γ-linkage, which shields GSH from 
hydrolysis by intracellular peptidases (Wu et al., 2004). The mammalian GCL is a 
heterodimer enzyme comprising approximately 73-kDa catalytic (heavy) subunit, 
GCLC, and approximately 28-kDa modulatory (light) subunit, GCLM. Only GCLC 
L-glutamate + L-cysteine + ATP       GCL      γ-L-glutamyl-L-cysteine + ADP + Pi. 
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has all the enzymatic activity which is subject to feedback from GSH. GCLM has 
no enzymatic action; on the other hand, the relationship of GCLM with GCLC 
diminishes the Km value (concentration of the substrate which allows the enzyme 
to achieve half maximal reaction rate) for glutamate and increases the Kl value 
(inhibition constant, defined as the concentration of the inhibitor required to 
produce half maximal inhibition of a reaction rates) for the feedback hindrance of 
GSH (Aoyama & Nakaki, 2013). In the second step, the γGluCys is consolidated 
with glycine (Gly) in a reaction catalysed by GS to form GSH (Fig 1.1 and Reaction 
2) (Wu et al., 2004). The GSH pathway occurs in virtually all cell types.  
                                                                                                               
 
                                                                                                           [Reaction 2] 
γ-L-Glutamyl-L-cysteine +Glycine+ ATP     GS        -L-glutamyl-L-cysteinyl-
glycine + ADP + Pi (Dickinson & Forman, 2002) 
http://etd.uwc.ac.za
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Figure 1.1: Glutathione formation and recycling. The production of GSH occurs by two 
mechanisms. De novo synthesis which occurs in a two-step reaction catalysed by two 
separate enzymes, GCL and GS; and recycling of GSSG via the glutathione reductase 
(GSR) enzyme, a reaction requiring nicotinamide adenine dinucleotide phosphate 
(NADPH). During oxidative stress, GSH is utilised to neutralise reactive oxygen species 
leading to the formation of GSSG (Guilford & Hope, 2014).  
 
1.1.3 Current concepts: structure and functions of GSH 
 
Cellular glutathione exists in two forms: the thiol-reduced GSH and glutathione 
disulfide oxidised form (GSSG). Eucaryotic cells have three major repositories of 
GSH. Almost 90% of cellular GSH is found in the cytosol, while 10% is found in 
the mitochondria and an insignificant minute amount in the endoplasmic reticulum 
(Lu, 1999, 2009). In the endoplasmic reticulum, where GSH is implicated in protein 
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disulfide bond shaping the GSH to GSSG proportion is 3:1, while in the cytoplasm 
and mitochondria, proportions surpass 10:1 (Lu, 1999).  
The peptide bond linking glutamate and Cys of GSH is through the γ-carboxyl 
group of glutamate instead of the routine α-carboxyl group (Fig 1.2). This unusual 
arrangement is subject to hydrolysis by only one known enzyme, called γ-
glutamyltranspeptidase (GGT), which is just present on the external surfaces of 
certain cell types. As a result, GSH is resistant to intracellular degradation and is 
exclusively metabolised extracellularly by tissues with GGT (Lu, 1999). GSH 
serves several functions which include 1) detoxifying electrophiles; 2) scavenging 
free radicals; 3) maintaining the essential thiol status of proteins; 4) providing a 
reservoir for Cys; and 5) modulating critical cellular processes such as DNA 
synthesis, microtubule-related processes, and immune function (Lu, 2009).  
At the blood-brain barrier (BBB) level, GSH has been revealed to play an important 
role in maintaining its integrity (Agarwal & Shukla, 1999). GSH has been shown 
to protect against the compromising tight junction (TJ) proteins (Song et al., 2014). 
 
Figure 1.2: The structure of glutathione - γ-glutamyl cysteinyl glycine (Lu, 2009). 
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1.1.3.1 Detoxifying functions of GSH 
 
Detoxification of xenobiotics or their metabolites is one of the significant functions 
of GSH. These compounds are electrophiles or electron-acceptor substances and 
they are structurally conjugated with GSH either spontaneously or enzymatically in 
interactions catalysed by GSH-S-transferase (Lu, 2009). The conjugates formed are 
usually excreted from the cell or into bile as in the case of hepatocytes.  
The metabolism of GSH conjugates starts with cleavage of the γ-glutamyl moiety 
by GGT, leaving a cysteinyl-glycine conjugate. The cysteinyl-glycine bond is then 
severed by dipeptidase, resulting in a cysteinyl conjugate (Lu, 2009). This is 
followed by N-acetylation of the cysteine conjugate, forming a mercapturic acid 
(Fig 1.3), which starts either in the gall bladder, intestine, or kidney. However, the 
formation of the N-acetylcysteine conjugates mostly occurs in the kidney (Lu, 
2009). Numerous endogenously formed conjugated compounds follow similar 
metabolic pathways as exogenous compounds. Most of the conjugated molecules 
that interact with GSH result in the detoxification of the compound, which could 
also be highly reactive (Lu, 2009).  
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1.1.3.2 Antioxidant function of GSH 
 
All aerobic organisms are subject to a certain level of physiological OS from 
metabolic processes. The intermediates that are formed, such as superoxide (O2-) 
and hydrogen peroxide (H2O2), can prompt the generation of toxic oxygen radicals 
that can bring about lipid peroxidation and cell injury (Garcia-Ruiz & Fernandez-
Checa, 2006). To prevent this, the endogenously produced H2O2is lessened by GSH 
in the presence of selenium-dependent GSH peroxidase. In the process, GSH is 
oxidised to GSSG, which thus is reduced to GSH by GSSG reductase at the expense 
of NADPH, forming a redox cycle.  
Figure 1.3: Detoxifying action of GSH through the mercapturic pathway (Lu, 2009). 
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Hydrogen peroxide is catabolised and converted to water through the oxidation of 
GSH to GSSG by GSH peroxidase (Fig 1.4) (Lu, 2009). Either GSH peroxidase or 
GSH S-transferase can decrease organic peroxides. Hydrogen peroxide can 
likewise be decreased by catalase, which is available exclusively in the 
peroxisomes. In the mitochondria, GSH is especially important because there is no 
catalase. Thus, mitochondrial GSH is crucial in defending against physiologically 
and pathologically generated OS (Garcia-Ruiz & Fernandez-Checa, 2006).  
Serious OS can exceed the ability of the cell to reduce GSSG to GSH leading to an 
accumulation of GSSG. To protect the cell from a detrimental shift in the redox 
equilibrium, GSSG can be actively exported from the cell or react with a protein 
sulfhydryl group (PSH) leading to the formation of a mixed disulfide (PSSG). Thus, 
severe OS exhausts cellular GSH (Lu, 2009). 
 
 
 Figure 1.4: The antioxidant function of GSH (Lu, 2009) 
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1.1.3.3 Glutathione’s role in cell proliferation 
 
Glutathione plays a crucial role in the cell proliferation process and glutathione has 
been shown to be involved in the proliferation of many different cells, e.g., human 
fibroblast cells, hepatocytes, intestinal epithelial cells, lymphocytes, and mouse 
bone marrow cells (Ashtiani et al., 2013). GSH is able to affect cell proliferation in 
various ways, and as an intracellular antioxidant has a key role in factors activating 
regulation like P38 mitogen-activated protein kinases (P38-MAPK) and Jun N-
terminal kinases (JNK). Also, this role has a direct relationship with intracellular 
GSH concentration. When the intracellular GSH concentration increases, activation 
of P38-MAPK and JNK can be inhibited (Cuadrado et al., 2003).  
GSH acts as an inhibitor for alkyl agents, for example, N-methyl-N-nitro-N-
nitrosoguanidine methyl and methane sulfonate. Through this inhibition, the 
activated P38-MAPK, JNK, and B-cell lymphoma 2 anti-apoptosis lead to 
apoptosis inhibition and increased proliferation (Cuadrado et al., 2003).  
The relationship between the GSH and ROS is one of the most influential metabolic 
processes influencing cell proliferation. ROS, particularly O2 and H2O2 play a key 
role in cellular death and proliferation (Ashtiani et al., 2013). These elements 
usually stimulates cellular growth in sub-micromolar concentration, whereas, at 
high concentrations (between 10 to 30 µM), they can result in apoptosis and 
necrosis  (Ashtiani et al., 2013).  
Indeed, the high concentration of this compound causes activation of transcription 
factors like the nuclear factors erythroid 2-related factor 2 and Kappa B (NF-кB) 
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and mitogen-activated protein kinases. Cellular death follows while low 
concentrations cause activation of different transcription factors, like antioxidant 
response element (ARE) (for example nuclear factor erythroid 2 Nrf2) (Day & 
Suzuki, 2005). The ARE transcription factor has a role in the enzyme γ-GCS gene 
expression regulation. This enzyme catalyses the rate-limiting step in GSH 
synthesis is in response to a xenobiotic. The result of this activation occurs after 
cellular proliferation, because of the increase of the GSH concentration (Day & 
Suzuki, 2005). GSH can affect tumour necrosis factor-α (TNF-α) too. TNF-α is a 
cytokine that is released by macrophage - monocyte cells which play an important 
role in infection and immunology. Cytokine TNF-α hasmany roles to play in 
biologics like antitumour and cellular proliferation inhibitor (Ashtiani et al., 2013).  
 
1.1.4 Endothelial GSH and S-glutathiolation in the control of vascular 
integrity 
 
GSH influences vascular endothelial function, by affecting endothelial barrier 
permeability, angiogenesis, chemotaxis, cell apoptosis, constitutive and agonist-
induced adhesion molecule expression, endothelial-dependent vasodilation and 
leukocyte-endothelial adhesion responses (Li et al., 2012). The modulatory impact 
of GSH is accomplished through the scavenging of ROS, a crucial second 
messenger in numerous endothelial functions. For example, GSH appeared to 
attenuate H2O2-induced decrease in transendothelial electrical resistance by means 
of the negative regulation of the p38-MAP kinase, which affects cell signalling with 
consequent cytoskeletal changes (Li et al., 2012). 
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Under different circumstances such as in the presence of non-radical toxic 
molecules, GSH acts as a substrate for the detoxification enzymes, GSH S-
transferase and GSH peroxidase (Li et al., 2012). The role of S-glutathionylation in 
redox regulation of vascular function has been supported by a large body of 
evidence, ranging from cell signalling, protein folding and apoptosis, to cytoskeletal 
reorganisation. For example, in hypertensive vessels,  the thiolation of endothelial 
nitric oxide synthase (eNOS) is essential in the redox control of vascular tone 
(Tousoulis et al. 2012). 
 
1.1.5 Regulation of glutathione biosynthetic genes 
 
Each of the three key enzymes responsible for GSH biosynthesis is encoded by a 
single-copy gene in the diploid human genome (Dickinson & Forman, 2002). The 
complementary DNA for both GCL and GS genes have been cloned, and sequenced 
(Gipp et al. 1995). The five untranslated regions of both genes have been also 
cloned, sequenced and further elucidated for regulatory components that could 
mediate transcription in response to a stimulus. (Moinova & Mulcahy, 1998).  
Many elements, including those creating glutathione conjugates and those 
generating ROS, have been reported to stimulate GSH biosynthesis via increment 
transcription of GCL genes (Wild & Mulcahy, 2000). Sequence analysis and 
experimental manipulations employing reporter constructs of the five untranslated 
regions for human GCLC and GCLM genes have revealed several putative 
enhancer components. These could mediate, either alone or in combination, an 
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increase in transcription in reply to the binding of transcription factors, whose 
activity has been increased in response to a stimulus signalled by the presence of 
some element (Dickinson & Forman, 2002). The GCLC promoter contains 
numerous potential cis-acting compounds, including consensus recognition sites for 
binding of Sp-1, activator protein-1(TRE), TRE-like, activator protein-2, nuclear 
factor kappa B (NFkB), and the electrophile response element (EpRE, sometimes 
called the ARE) binding complexes (Dickinson & Forman, 2002). The GCLM 
promoter is activated by a large number of the same compounds, which also activate 
the GCLC promoter, with the notable exception of the kappa B compound. Of the 
above-mentioned enhancer components, those that have received the most attention 
have been TRE or TRE-like elements and EpRE elements. The part of these 
components in intervening GCL transcription in response to different stimuli has 
been reviewed previously (Dickinson & Forman, 2002). 
GSH is one of the most abundant naturally occurring thiol-based antioxidant (AO) 
within mammalian cells. GSH play pivotal role in the cellular mitigation of OS 
among other functions such as oxidation-reduction reactions in metabolic pathways 
and redox signaling (Abegg et al., 2012). Although, in some other cell types the 
presence of GSH, GSH content and its capacity to fight ROS has been established, 
it has not been scientifically reported in the brain endothelial cells or cell lines.  
 
1.1.6 Trolox 
2 Trolox is a peroxyl radical 
3 scavenger that rapidly penetrates biological membranes 
Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) is an exogenous 
antioxidant derived from water-soluble vitamin E, which penetrates biomembranes 
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and protects mammalian cells from oxidative damage. Trolox, a chain-breaking 
antioxidant, acts as a scavenger of radicals via the H-donating group in its 
chromanol nucleus. Furthermore, it is used in biochemical or biological 
applications to reduce OS or damage (McClain et al., 1995). Trolox, which has high 
AO potential, has been shown to reverse certain detrimental effects of EtOH on the 
BBB (Ramirez et al., 2009). 
 
1.2 Blood-brain barrier  
1.2.1 Overview 
 
The BBB is an active complex signalling and a regulatory interface between the 
central nervous system (CNS) and the circulatory system, which insulates the brain 
from the plasma (Hawkins et al., 2006). The BBB is a specialised endothelial 
structure that forms the microvasculature of the brain, also prohibits the entry of 
harmful blood-borne substances into the brain microenvironment, such as many 
toxic compounds and pathogens (Abbott et al., 2010). Furthermore, it functions by 
controlling the exchanges of substances such as molecules, ions and immune cells 
that take place between the brain and the blood circulation, and thus is primarily 
responsible for the maintenance of the CNS homeostasis. 
The brain microvascular endothelial cells (BMECs) paracellular pathway is 
regulated by TJs (Furuse & Tsukita, 2006). Thus, barrier properties of the BBB are 
contributed mainly by the specialised endothelial cells (ECs) of the CNS 
microvasculature (Abbott et al., 2010). The BBB is indicative of a barrier that 
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demonstrates exceptionally regulatory epithelial and endothelial properties (Malaeb 
et al., 2012). 
The BBB regulates the entry of water and ions, and a number of nutrients including 
small lipophilic molecules as well as regulated transported via receptor-mediated 
transcytosis (e.g. glucose, some amino acids, heparin, and transferrin). Under 
normal physiological conditions of the CNS, and because of the BBB permeability, 
plasma-borne macromolecules, and most cellular elements are restricted from 
crossing the BBB (Lossinsky & Shivers, 2004; Malaeb et al., 2012). 
The BBB exists in all brain regions, excluding the circumventricular organs. These 
including the median eminence, neurohypophysis, pineal gland, sub-fornical organ, 
and lamina terminalis. These capillaries possess fenestrations which allow for 
diffusion of blood-borne molecules across the vessel wall. This allows the 
autonomic areas of the brain to sense variables of blood plasma, such as the 
concentrations of carbon dioxide (CO2), H+ ions glucose concentration, and 
lipostatic status of blood. These unprotected areas of the brain are an important 
interface (with the blood) responsible for the regulation of the autonomic nervous 
system and endocrine glands of the body. The latter allowing secretion of hormones 
into the blood to regulate distal anatomical and physiological systems (Cardoso et 
al., 2010; Malaeb et al., 2012). 
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1.2.2 Anatomical structure of the blood-brain barrier  
 
The BBB endothelium of mammals, including humans, is created by thin, flat cells 
known as brain endothelial cells (BEC) that form walls of the cerebral capillaries 
(Pfeiffer et al., 2011). The layers between the blood and brain: consist of the EC 
capillaries, a basement membrane (BM) covering the outside capillaries, and 
specialised cells, called pericytes, between the endothelium and the BM, and 
astrocyte “foot-like” processes that are confined to the outside of the BM. Each of 
these components could potentially play a role in restricting the movement of 
solutes by regulating the trans endothelial permeability (Pfeiffer et al., 2011). The 
brain capillary endothelium interact with other cell types of the neurovascular unit 
(NVU), such as astrocytes, pericytes, perivascular microglia, and neurons to 
regulate the transport of substances across the BBB (fig 1.5) (Nakagawa et al., 
2007; Yang et al., 2007). 
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Figure 1.5: Schematic representation of the cross-section NVU of the BBB (Abbott et al., 
2006). The NVU consists of the primary endothelial cells which are regulated by the 
astrocyte (end feet) and pericytes. 
 
Brain endothelial cells are the key component controlling the BBB permeability, 
but interactions with astrocytes and pericytes are essential for the regulation of 
barrier function. For the explanation of these functions of the astrocytes and 
pericytes see Sections 1.2.2.3 and 1.2.2.4. (Kaur & Ling, 2008; Wolburg & 
Lippoldt, 2002).  
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1.2.2.1 Basement membrane  
 
The BM is a thin, fibrous, a cellular element that separates pericytes, and astrocytes. 
The BM is the essential part of the BBB which appears in scanning electron 
microscopy as thin, tightly interwoven protein sheets (Engelhardt & Sorokin, 2009). 
The BM surrounds the vascular tube in two layers, the inner vascular layer and the 
outer parenchymal layer, also known as the vascular glia limitans perivascular 
(Daneman & Prat, 2015). The functions of the BM is to ensure anchorage of the 
NVU and establish a connection with the surrounding resident cells. The BM is 
crucial to the morphological and functional orientation of the BEC into apical and 
basolateral cellular domains (Daneman & Prat, 2015). 
 
1.2.2.2 Brain endothelial cells  
 
Brain endothelial cells are the most the most important component of the BBB, are 
shaped as simple squamous cells which are modified from the mesodermally 
derived cells (Daneman & Prat, 2015). Comparing the CNS ECs with those in other 
tissues, the CNS ECs are fundamentally different from other vascular endothelial 
in their ability to regulate the movement of molecules to and from the neural 
parenchyma (Cardoso et al., 2010). Also, they have higher amounts of mitochondria 
compared to other ECs. Moreover, CNS ECs express an extremely low level of 
leukocyte adhesion molecules, and they also lack pinocytic vacuoles, all of which 
contribute to the regulated permeability of the BBB (Daneman & Prat, 2015). 
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1.2.2.3 Pericytes  
 
Pericytes are important cellular components of the NVU (Cardoso et al., 2010), 
which surround the abluminal surface of the cerebral capillaries of the endothelial 
tube and are completely enclosed by the BM. In the NVU, pericytes are thought to 
be responsible to synthesise growth factors and some BM components, and their 
association with the BEC, are essential for the structural maintenance of the BBB 
including junctional integrity (Cardoso et al., 2010; Daneman & Prat, 2015). 
Pericytes participate in the regulation of EC proliferation and migration and play an 
essential role in the mediation of inflammation as proposed by Cardoso et al. 
(2010).  
 
1.2.2.4 Astrocytes 
 
Astrocytes constitute the most numerous cell classes in the CNS. They have a 
stellate morphology and their end feet are structured to form a lacework of fine 
lamellae closely opposed to the exterior surface of the BBB endothelium and its 
respective BM (Abbott, 2002; Daneman & Prat, 2015). (Abbott, 2002; Daneman & 
Prat, 2015). At the BBB level, astrocyte end feet connect neurons and blood through 
close association, connecting the neurons in the brain to brain blood vessels 
(Bernacki et al., 2008). Astrocyte plays a critical role in the maintenance of the 
barrier properties, especially affecting the functions of the BEC. According to 
reports, they also have the ability to control the cerebral blood flow (Abbott et al., 
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2010; Liebner, Czupalla et al., 2011). During development, astrocytes modulate 
angiogenesis and endothelial TJ formation by releasing neurotrophic and growth 
factors (Zhao et al., 2006). In addition, the astrocyte makes provision for essential 
modulatory factors, for example, tissue growth factor beta , interleukin-6, and glial 
fibrillary acidic protein (GFAP). Astrocytes with deficient GFAP are reported to 
have an inability in enhancing BBB properties (Wilhelm et al., 2011). Thus, the 
astrocytes’ role is multifaceted, since it is included in the induction, repair, and 
maintenance of the BBB and in the angiogenesis of the brain capillaries (Weiss et 
al., 2009). 
 
1.2.3 Inter-endothelial junctions  
 
The BEC that form the BBB is stabilised by specialised cell junctions between 
adjacent cells (Cardoso et al., 2010). At the BBB level, there are two kinds of inter-
endothelial junctions: TJs) and adherens junctions (AJ) (Fig 1.6). 
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Figure 1.6: Structure of BBB inter-endothelial junctions (Abbott et al, 2010). 
 
1.2.3.1 Tight junctions  
 
Tight junctions have been identified as the main structures responsible for the 
barrier properties. They are molecular contacts between adjacent cerebral 
endothelial cells, set on the apicolateral sides of BEC. A TJ has the ability to seal 
the space between neighbouring cells allowing only limited passage of water but 
prevent other substances from entering the brain (Cardoso et al., 2010). 
Structurally, TJs consist of transmembrane proteins such as the claudins (3 but 
mainly 5), occludins, as well as a cytoplasmic of accessory and regulatory proteins 
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which include zonula occludens proteins (ZO-1/2/3) and cingulin (Cardoso et al., 
2010).  
These accessory or scaffolding proteins couple the junctional transmembrane 
proteins to actin filaments of the cytoskeleton, for the maintenance of the structural 
and functional integrity of the BEC. Transmembrane phosphoproteins consist of the 
major extracellular elements of TJs creating the paracellular barrier. They mediate 
cell-to-cell adhesion via homophilic interactions and might have a regulatory role 
related to BBB permeability and transendothelial migration of leukocytes (Lawther 
et al., 2011). A disrupted TJ could result in the uncontrolled entry of potentially 
damaging agents and transmit toxic effects to remote sites in the brain (Sambuy, 
2009). 
 
1.2.3.1.1 Claudin 
 
Claudins belong to 20–28 kDa integral membrane phosphoproteins family 
comprising four transmembrane domains (Romanitan et al., 2010), and are 
genetically encoded by a multigene family of 24 distinct affiliates (Furuse & 
Tsukita, 2006; Malaeb et al., 2012). The belief is that claudins are the primary 
constructive component of TJs and responsible for their seal formation, and which 
regulate the specificity of TJ permeability. Their role in response to cellular stress 
were also suggested to play a part in the regulation of embryonic morphogenesis 
(Cardoso et al., 2010; Romanitan et al., 2010).  
Claudins appear to be expressed in all tissue types, and although in mammalian 
BEC, the presence of claudin-1, -2,-3, -5, -11, -12 and -18 has been reported 
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(Cardoso et al., 2010; Romanitan et al., 2010). However, most dominant the 
claudins expressed by BEC is claudin-5 (Romanitan et al., 2010). Claudins bind to 
cytoplasmic proteins ZO-1, ZO-2, and ZO-3 by their carboxy-terminal. Moreover, 
claudins, as with occludins, extend over the plasma membrane four times, through 
two extracellular loops, with both -NH2 and -COOH terminals in the cytosol. 
Claudins are homotopically bound to other claudins on neighbouring ECs which 
establishes the seal function of the TJs (Ballabh et al., 2004). At the BBB level, 
claudin-5 is one of the most studied members of the TJ, which has been shown to 
play one of the many important roles in the NVU. First, its ability to maintain 
normal BBB function (Vorbrodt & Dobrogowska, 2003) which is supported by the 
fact that down-regulation of claudin-5 expression is correlated with a breakdown of 
the BBB (Argaw et al., 2009), and second, it appears to play an important role 
during angiogenesis and in disease processes in regulating increased vessel 
permeability (Cardoso et al., 2010). 
 
1.2.3.1.2 Occludin 
 
Occludin is a 65 kDa integral membrane TJ protein, has four transmembrane 
domains (Hawkins & Davis, 2005), was the first tight junctional integral membrane 
protein discovered (Zlokovic, 2008). At the BBB level, occludin is not essential for 
the creation of TJ (Hawkins & Davis, 2005). Indeed, the results of many 
experiments have shown that loss of occludin can be compensated by normal 
expression and localisation of other junctional proteins (Zlokovic, 2008). Occludin 
function as an active regulatory protein, and has been assumed to be the physical 
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basis of the TJ barrier but has since been disputed. In addition, occludin-deficient 
mice are viable and exhibit normal barrier function (Findley & Koval, 2009). 
However, it has been suggested that occludin could act as an additional support 
structure with regulatory functions, which maintain electrical resistance and 
aqueous pore formation. In fact, high levels of occludin reduce paracellular 
permeability and high electrical resistance of the BEC monolayers, which 
underlines an active role of occludin in BBB function (Cardoso et al., 2010). The 
presence of occludin in the membrane is associated with augmented electrical 
resistance across the membrane and thus, diminished paracellular permeability 
(Huber et al., 2002).  
 
1.2.3.2 Adherens junctions  
 
Adherens junctions mediate the adhesion of ECs to each other to the BM. AJs 
consist of two fundamental adhesive units, cadherin/catenin, and nectin/afadin 
complexes(Lawther et al., 2011). These join the actin cytoskeleton via intermediary 
proteins (catenins) to create adhesive contacts between cells. Together TJ and AJ 
elements, especially ZOs and catenins are known to interact and further restrict 
permeability across the endothelium (Lawther et al., 2011). 
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1.2.4 Transport at the BBB  
 
The passage of molecules across the EC of the BBB can occur between 
neighbouring cells (the paracellular pathway) or via the cells (the transcellular 
pathway) (Cardoso et al., 2010). Despite its barrier properties, lipophilic solutes can 
cross the BBB, as a result of their membrane solubility, (Schrot et al., 2005). Small 
inorganic molecules (e.g. oxygen, CO2, nitric oxide, and water) diffuse across the 
endothelium membranes with ease as a result of their concentration gradient 
(Lawther et al., 2011). Other essential solutes necessary for brain function, such as 
glucose and amino acids, are transported by a specific carrier for example, Glut-1 
and leucine-preferring or the L-type transport proteins, respectively. 
Certain molecular elements with suitable molecular weight, charge as well as 
lipophilicity, might diffuse from the blood into the CNS (Fig 1.7) (Gabathuler, 
2010). Various elements associated with the opening of the BBB are suggested to 
emerge as a result of receptor-mediated processes, by activating the signal 
transduction pathways within the endothelium (Abbott, 2002). Polar and lipid-
insoluble molecules do not have the ability to cross the BBB (Cardoso et al., 2010). 
Some narcotic lipophilic molecules, such as alcohol, methamphetamine and 
nicotine can diffuse across the brain without restrictions. This ability to freely 
diffuse is governed by the transendothelial concentration, molecular size, charge, 
and lipophilicity (Gabathuler, 2010; Pardridge, 1995). 
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Figure 1.7: Routes of transport across the BBB (Abbott et al., 2010) 
 
1.2.5 Permeability and pathophysiology of the BBB 
 
Reactive oxygen species contributes to the disruption of the BBB as well as 
inflammation of the brain and induced cellular migration affecting BBB integrity 
by causing cytoskeletal rearrangements besides modifying the TJ proteins, claudin-
5 and occludin (Schreibelt et al., 2007). The carboxy-terminal parts of occludin and 
claudins work together with the membrane-related recruiting proteins of the ZO 
protein family (Schreibelt et al., 2007). The proposed function of the ZO proteins 
is to connect transmembrane proteins to the actin cytoskeleton and may also be 
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involved in cellular signalling. During its contact with TJ molecules, the actin 
cytoskeleton plays a significant role in maintaining TJ integrity. Protein tyrosine 
kinases  may possibly be activated in BEC which could progress to tyrosine 
phosphorylation of TJ proteins as a result of ROS (Schreibelt et al., 2007). Popescu 
(2013) hypothesised that Rho and other small Guanosine triphosphate influence the 
expression of TJ proteins, occludin and claudin-5 in various epithelial models. A 
chief mechanism influencing BBB permeability that has been shown, is the ROS-
induced redistribution and down-regulation of claudin-5. Exogenous ROS 
transforms the organisation of occludin and ZO-1 in BEC (Schreibelt et al., 2007).  
Experimentally-generated peripheral inflammation enhances BBB permeability 
and results in decreased occludin expression (Huber et al., 2002; Popescu, 2013) 
and augments expression of claudin-3 and -5 (Brooks et al., 2005; Popescu, 2013). 
The extravasation of plasma proteins associated with BBB dysfunction could occur 
through transcellular or paracellular routes, via the induction of fluid-phase or 
nonspecific pinocytosis and transcytosis, the formation of transendothelial 
channels, or disruption of the EC membrane TJ (Grant et al., 1998). Efflux 
transporters, such as P-glycoprotein, are important as they enhance barrier 
properties. They do this by returning the small lipophilic molecules that disseminate 
into the BEC, back to the bloodstream (Lippmann et al., 2012; Pardridge, 2003). 
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1.2.6 The BBB and diseases 
  
There is a long list of CNS pathologies involving alterations in structural and 
functional elements of the BBB, including multiple sclerosis, hypoxia, ischemia, 
oedema, Parkinson's disease, Alzheimer's disease, epilepsy, tumors, glaucoma and 
lysosomal storage diseases (Abbott et al., 2010). Vascular leakage may possibly 
cause the disruption of the BBB, the chief pathophysiological mechanism of most 
CNS diseases (Brown & Davis, 2002). The barrier dysfunction can range from 
gentle and transient TJ opening to chronic barrier breakdown and changes in 
transport systems and enzymes can likewise occur (Abbott et al., 2010). Toxic 
agents and pathological conditions may compromise BBB function through an early 
change in its function which is mediated through direct effects on the ECs and 
associated with morphological changes in astrocytes (Cardoso et al., 2010). 
Microglial activation is increasingly recognised as an early indication of CNS 
inflammation, even in disorders not previously regarded as inflammatory (Abbott 
et al., 2010). The inflammation is a concern factor indicated in BBB alterations 
throughout CNS diseases. Indeed, in all the neurological disorders, the CNS show 
inflammatory features (Stolp & Dziegielewska, 2009). 
 
1.2.7 The immortalised bEnd5 cell line as an in vitro blood-brain barrier  
 
The immortalised mouse brain endothelial cell line (bEnd5) is composed of spindle-
shaped cells (Steiner et al., 2011). It has been established as a cell line from isolated 
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mouse BEC by using polyoma virus middle T-antigen (Reiss et al., 1998; Steiner 
et al., 2011; Yang et al., 2007). This cell line expresses three junction proteins, 
occludins, claudin-5, and Zona occludins-1, besides von Willebrand factor, vascular 
endothelial-cadherin, platelet endothelial cell adhesion molecule-1, intercellular 
adhesion molecule-2, endoglin and transporters such as glucose transporter-1, P-
glycoprotein, sodium-potassium chloride-/NKCC co-transporters, and most protein 
kinase C isoforms (Paolinelli et al., 2013; Yang et al., 2007).  
The bEnd5 cells simulate the barrier properties of the BBB, similar to the primary 
mouse brain microvascular endothelial cell (pMBMEC) (Coisne et al., 2005; 
Röhnelt et al.,1997). The bEnd5 and pMBMEC cells are associated with the 
establishment of a highly restrictive barrier which minimises the permeability 
across the in vitro BBB model (Coisne et al., 2005; Röhnelt et al.,1997). A 
disadvantage of bEnd5 cells may include the observation that continuous sub-
culturing of the cells could result in a change of occludin expression and incomplete 
TJ generation. On the other hand, immortalised bEnd5 cells, when compared to 
primary cell cultures, are more reproducible and require less time to culture 
(Lundquist et al., 2002). 
 
1.2.8 The proposed in vitro blood-brain barrier model 
 
A challenge to BBB research is the scarcity of reliable in vitro models to concentrate 
the cellular and molecular mechanisms of BBB function under pathological and 
normal conditions (Yang et al., 2007). The BBB in vitro models are composed of 
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EC culture systems derived from brain microvascular cells BMCs. Primary brain 
ECs are isolated by using an enzymatic digestion, typically using various sets of 
enzymes such as dispase or collagenase (Cecchelli et al., 1999). In earlier studies, 
the primary cultured ECs of brain capillaries which were retrieved by the utilisation 
of mechanical filtration and homogenisation were used (Cecchelli et al., 1999). 
Subsequently, there has been a significant advancement in cell culture, with choices 
of using well-established protocols for primary cell cultures or using commercially 
available immortalised cell lines.  
Significant advantages of in vitro BBB models which utilise immortalised cell lines 
include decreased variability and also conceivable high throughput of experimental 
treatment (Coisne et al., 2005). The in vitro model is helpful in that it diminishes 
animal utilisation in experiments, and furthermore, BBB models can retrieve useful 
information about the transport mechanisms for a specific medication or treatments 
in a timeous manner (Weidenfeller et al., 2005). This is achievable because it 
features derivable information on basic mechanisms of individual components of 
the BBB eliminating other BBB elements, e.g. astrocytes or pericytes which could 
cloud the investigations, thus allowing for faster and greater profiling of treatments 
(Weidenfeller et al., 2005).  
With reference to the immortalised bEnd5 cell line, not only does it express 
unmistakable cellular markers of ECs of the in vivo BBB of humans, and that of the 
mouse, but is also in alignment with the laboratory in vivo mouse model. 
Consequently, there is enough motivation to use this immortalised cell line in 
research studies (Mentor & Fisher, 2017). 
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1.3 Reactive oxygen species  
 
ROS are small, extremely reactive, oxygen-containing molecules, naturally 
produced in minute quantities during metabolic reactions in the body (Wu et al., 
2003). ROS consist of free radical atoms which contain an unpaired electron, 
therefore making them inherently unstable and highly reactive. Various kinds of 
ROS include O2-, H2O2 and the hydroxyl radical (OH.) (Betteridge, 2000). The 
potential sources of ROS are from an assortment of cellular enzyme systems, 
including oxidase, arachidonic acid metabolising enzymes, including cytochrome 
P-450 enzymes, xanthine oxidase, uncoupled endothelial nitric oxide synthase, 
lipoxygenase and cyclooxygenase, and mitochondrial metabolic processes (Zhang 
& Gutterman, 2007). The mitochondrial metabolic process is a major source of 
ROS in most mammalian cell types. In mitochondria, the electron transport chain 
is the primary site of ROS production. In vascular ECs, ROS under normal 
physiological conditions, has the ability to regulate vascular tone, oxygen sensing, 
cell division and apoptosis, and inflammatory responses (Zhang & Gutterman, 
2007). 
OS is an expression used to depict various injurious processes consequent from an 
imbalance between an increase in the formation of ROS and/or reactive nitrogen 
species and its destruction by the limited capacity of antioxidant defences (Turrens, 
2003). Uncontrolled increases in the steady-state concentrations of those oxidants 
lead to free radical-mediated chain responses that indiscriminately target proteins 
(Stadtman & Levine, 2000; Turrens, 2003), DNA, lipids and polysaccharides 
(Turrens, 2003). However, cells are equipped to check the oxidative assault with 
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many cellular antioxidant defences such as GSH, catalase and dismutases (Freeman 
& Keller, 2012). In the mitochondria and cytosol, H2O2 can be diminished by 
glutathione peroxidase, which utilises GSH to neutralise H2O2 and lipid peroxides 
to water and equivalent alcohols, respectively  (Zhang & Gutterman, 2007).  
The BBB endothelial cells have a high concentration of mitochondria, providing an 
increased opportunity for creating OS (Freeman & Keller, 2012). Under normal 
conditions, the integrity of the BBB is shielded from OS because BBB cells contain 
high levels of antioxidant enzymes (Plateel et al., 1995; Tobwala et al., 2014). 
Increased OS can lead to neurodegeneration and breakdown of the BBB through 
the disturbance of TJ proteins which can change flowing of the bloodstream 
(Freeman & Keller, 2012). 
OS is one of the most important mechanisms responsible for the interruption of the 
BBB, which permits the entry of toxic substances into the brain, leading to the 
development of, and progression of several neurological diseases (Tobwala et al., 
2014). During different disease stages and ageing, the antioxidant defence systems 
can be compromised leading to progressive oxidative harm and subsequent 
significant loss of function and/or cell death (Freeman & Keller, 2012). GSH 
decreases ROS levels and activates cellular OS responses using many mechanisms 
(Song et al., 2014).  
At the point when OS occurs, cells neutralise the consequential oxidant impact to 
restore the redox equilibrium. All organisms have adaptive responses to OS, for 
example, activation of genes encoding defensive enzymes, transcription factors, 
and structural proteins (Emerit et al., 2004). Fortunately, the cell has its own 
internal defence mechanism to battle against OS. Principally, this is intervened by 
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the transcription factor NF-E2-related factor (Nrf2), which is responsible for 
controlling a series of antioxidant and cellular protective genes, in response to OS 
(Shelton & Jaiswal, 2013). Under OS, Nrf2 becomes activated and translocates 
from the cytoplasm to the nucleus and subsequently activates the transcription of 
antioxidant genes. The promoters of these AO genes contain the ARE and research 
evidence has shown that Nrf2 promotes cell survival by preventing expansion in 
ROS under different conditions of OS (Song et al., 2014). 
In a few studies, GSH was found to inhibit cell death in OS (Abramov et al., 2007). 
In addition, Song et al., (2014) demonstrated that GSH protects DNA against OS, 
and also GSH neutralises the generation of ROS under OS. 
 
1.3.1 Influence of ROS and endothelial barrier dysfunction  
 
There is abundant evidence to demonstrate that OS induced by ROS like O2−, H2O2, 
or HO- can elicit endothelial barrier dysfunction (Lum & Roebuck, 2001). In 
addition, oxidant stress of the endothelium also increases the intracellular calcium 
concentration ([Ca2+]i) which correlates with expanded endothelial permeability 
(Fig 1.8) (Lum & Roebuck, 2001). Also, oxidants such as H2O2 appear to increase 
the phosphorylation of myosin light chain kinase indicating that ROS can contribute 
to endothelial barrier dysfunction and alter endothelial contraction (Hawkins & 
Davis, 2005). The paracellular permeability in the endothelium is controlled by the 
TJ and intercellular endothelial AJ (Hawkins & Davis, 2005). H2O2-induced barrier 
disruption appears to occur through rearrangement of β-catenin, the disruption of 
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β-catenin/cytoskeletal association and endothelial cadherin, but the signalling 
events remain to be resolved.  
However, occludin phosphorylation and activation of ERK1/ERK2 signalling 
appeared to mediate the disruption of occludin-ZO-1 interactions on endothelial cell 
surfaces and cause the disorganisation of occludin (Li et al., 2012). ROS is able to 
activate signalling pathways, for example, may further regulate the phosphorylation 
state of TJ proteins and other AJ (Konstantoulaki et al., 2003). 
 
 
Figure1.8: Mechanisms of MG-mediated endothelial barrier dysfunction and its 
protection by GSH (Li et al., 2012) 
 
From the foregoing discussion, it is apparent that GSH has an important role to 
play in the protection of the BBB against OS-induced dysfunction. It is rational to 
consider the use of antioxidant agents in the treatment of BBB dysfunction-linked 
neurological disorders. However, objective judgement regarding the point in the 
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progression of a disease that will justify the use of exogenous antioxidants, will 
depend on the capacity of the endogenous system to neutralise ROS. This study 
aims to detect the presence of the GSH system within bEnd5 endothelium model 
of the BBB and to determine its quantity as well as evaluate its capacity to 
neutralise ROS   
 
1.4 Research aims and objectives 
1.4.1 Aims 
 
The aim of this study is to establish the presence of GSH in bEnd5 cells line model 
of the BBB, to quantify the amount of GSH in bEnd5 cells, and to evaluate 
functional capacity of the GSH content of bEnd5 cells. 
 
1.4.2 Objectives 
 
• To establish the presence of GSH in bEnd5 cells by using mBCL a 
fluorometrically based assay. 
• To quantify the amount of GSH and GSSH per cell in bEnd5 cells using a GSH-
GloTM Glutathione assay kit.  
• To evaluate the functional capacity of GSH in bEnd5 cell content by exposing 
the cell to increasing concentrations of H2O2. 
http://etd.uwc.ac.za
35 
 
• To determine if an exogenous treatment of an AO (Trolox) will increase the 
capacity of the endogenous antioxidant GSH.  
 
1.5 Research question/hypothesis 
 
The hypothesis for this study is that the GSH-based AO system of the bEnd5 cells 
have limited capacity to regulate the levels of ROS neutralisation in the in vitro 
model of the BBB.  
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CHAPTER TWO 
 
Methods and materials 
 
An in vitro analysis was carried out to establish the presence of GSH in bEnd5 cells. 
This would be achieved by quantifying the amount of GSH and GSSG in bEnd5 
cells. The final phase of the study was to evaluate the functional capacity of bEnd5 
cells to OS (exposure to H2O2 over 24 and 48 hours as well as in combination with 
Trolox) and its relationship to cellular GSH. 
 
2.1 Immortalised mouse brain endothelial cell line 
 
The bEnd5 cell line was obtained from ECACC, (Sigma-Aldrich, 96091930), which 
was established from BECs of BALB/c mice. Cellular immortalisation was 
imparted by transfecting the primary cells with the retrovirus coding for the 
polyoma middle T antigen (Reiss et al., 1998). The bEnd5 cells have an endothelial-
like morphology, and they also express endothelial-specific proteins, endoglin, 
PECAM-1, FIK-1, and MECA-32 (Reiss et al., 1998). 
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2.2 Mouse brain endothelial (bEnd5) cell culture procedure 
2.2.1 Chemicals required for bEnd5 cells culture procedure 
 
All reagents were obtained from Whitehead Scientific Pty Ltd, SA. The following 
chemicals were required for the culture of bEnd5 cells, foetal bovine serum (FBS) 
(biowest, S12010S181G), non-essential amino acids (NEAA) (Lonza, BE 13-
114E), antibiotic Penicillin-Streptomycin Amphotericin B mixture (Lonza, DE17-
602E), sodium pyruvate (Lonza, BE13-115E), Dulbecco’s modified eagle medium 
(DMEM) (Lonza, BE 12-719F). The mouse brain endothelial (bEnd5) cell line 
(Sigma-Aldrich, 96091930) ECACC, trypsin-EDTA (Lonza, 5MB042), phosphate 
buffer saline (PBS) (by Life Technologies Corp., Gibco,20012-019), and Trypan 
blue (by Life Technologies, Gibco, 15250-061).  
 
2.2.2 Brain endothelial (bEnd5) cell culture procedure 
 
The bEnd5 cells were grown in complete media (DMEM) F-12, supplemented with 
10% FBS, 1% sodium pyruvate, 1% Penicillin and Streptomycin, and 1% NEAA 
(Reiss et al., 1998; Steiner et al., 2011). The cells were grown in a 25 cm2 (50 ml) 
tissue culture (TC) flasks containing the desired amount of supplemented DMEM. 
Cells were incubated at 37°C and 5% CO2 at 95% humidity until the cell culture 
reached confluence. Every 24 hours cells were checked for media colour change, 
attachment and confluence, using an inverted-phase microscope. At 80-90% 
confluence, the bEnd5 cells were trypsinised and sub-cultured to routinely calculate 
http://etd.uwc.ac.za
38 
 
the required concentration of cells needed for the experiments. The bEnd5 cells 
used in this experiment were of passage numbers 17-25. These passage numbers 
were ensured by freezing away a large reserve of the low passage numbers. 
 
2.3 Fluorescence targeting of GSH 
2.3.1 Detection of glutathione in bEnd5 cells using the monochlorobimane 
fluorescence method 
 
The use of fluorescent probes to confirm the presence and to assay for glutathione 
in cultured cells has been well-reported (Baxter et al., 2015; Chatterjee et al., 1999; 
Hartmann et al., 2003). Monochlorobimane (mBCl) is a non-fluorescent bimane 
that passively diffuses across cellular membranes into the cytoplasm, and 
selectively and enzymatically conjugates with GSH to form fluorescent glutathione 
S-bimane (GSB) (Fig 2.1), which can be fluorometrically assayed (Reiss et al., 
1998; Steiner et al., 2011). 
 
 
Figure 2.1: The reaction of monochlorobimane mBCl with glutathione (GSH)(Machado 
& Soares, 2012) 
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2.3.2 Coating tissue culture surface with collagen 
 
Rat-tail collagen was harvested in our laboratory using standard procedures and 
used to coat (10 µg/ml) the microscopy slides to improve bEnd5 cells adherence to 
glass surfaces and to mimic a BM. This allowed for the bEnd5 cells to 
physiologically and functionally orientate themselves with regard to their 
apicolateral and basolateral morphology. Collagen coating was done only for the 
microscopy experiments in which cells were grown on glass slides.  
  
2.3.3 Chemical requirements for the monochlorobimane fluorescence study 
 
The chemicals required for the monochlorobimane (mBCl) fluorescence study 
included collagen type 1, DABCO mountant (1, 4-diazabicyclo-[2,2,2]-octane) and 
mBCl solution, (mBCl, Molecular Probe TM M1381MP) that was prepared as a 33.3 
mM stock solution by dissolving 25 mg of 226.66 g/mol of mBCl in 3.3 ml of 
DMSO this stock solution was stored in the dark at -20ºC. A working solution with 
a final concentration of 60 μM was used. This solution (60 μM) was prepared by 
diluting the stock solution in DMEM immediately before use and directly added to 
the bEnd5 cells cultures.  
A solution of 4% paraformaldehyde and 0.2% glutaraldehyde in PBS, pH 7.4, was 
prepared and stored in the fridge. A 0.05 M PBS solution, pH 7.4, was prepared by 
using reagents that included 1 M Potassium Phosphate (Monobasic) solution 
(KH2PO4), 1 M Potassium Phosphate (Dibasic) solution (KH2PO4) Monobasic one 
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K and dibasic 2 K, and 5 M sodium chloride solution (NaCl). Additional stock 
solutions were prepared as follows: 10 ml of 1 M KH2PO4 (was prepared by 
dissolving 1.3609 g in 10 ml of double distilled water (ddH2O)), 50 ml of 1 M 
KH2PO4 (was prepared by dissolving 8.709 g in 50 ml of ddH2O) and 50 ml of 5 M 
NaCl (was prepared by dissolving 14.61 g in 50 Ml of ddH2O). Stock solutions 
were then filtered.  
Solutions of 0.05 M PBS, pH 7.4 stock were prepared by mixing 7.6 ml (1 M 
KH2PO4) with 42.4 ml (1 M dibasic KH2PO4) and 30 ml 5 M NaCl and then filled 
up to just under 1 liter with ddH2O to allow for pH adjustments that were checked 
and adjusted to the desired pH by adding either hydrochloric acid or KOH. 
 
2.3.4 Protocol for the monochlorobimane fluorescence study 
 
The microscopic glass slides which were first cleansed with 70% ethanol, wiped 
with tissue towel and then UV-sterilised were placed inside two groups of five Petri 
dishes (100*22 mm). The first group consists of plain glass slides while the second 
group consists of glass slides coated with rat-tail collagen (10 µg per ml), and each 
group has a control group and mBCl treated group. For the first group, an equal 
number of bEnd5 cells were seeded on the top of the glass slide in each of the Petri 
dishes, and cultures were incubated overnight at 37°C. For the second group, equal 
numbers of bEnd5 cells, as in the first group, were seeded on the top of the coated 
slide in each (100*22 mm) Petri dish, and cultures were incubated overnight at 
37°C. The experiment was terminated in each group by aspirating the media. After 
aspiration, the cells on each slide were rinsed twice in PBS and then fixed. 
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Coverslips were mounted on each slide using 10 µl DABCO mountant. The mBCl 
treated samples were exposed to 10 ml of 60 µM mBCl solution which was pipetted 
into each Petri dishes and allowed to incubate for 30 minutes at 37ºC. The 
experiment was terminated by aspirating the mBCl solution following which the 
slides were rinsed twice in PBS and then fixed. Coverslips were then mounted on 
each slide using 10 µl DABCO mountant. Cells in each slide were viewed and 
imaged under a fluorescent microscope (Nikon Eclipse) at (ex: 365-400 nm, em: 
450-490 nm). These experiments were carried out in triplicates. 
 
2.4 Quantification of glutathione per single bEnd5 cell 
 
2.4.1 Introduction  
 
The GSH-Glo™ Glutathione assay Kit (Promega, cat no V6911/2, lot 
0000155719), was used to quantify the amount of GSH in each cell. An equal 
number of bEnd5 cells were seeded in each well of the 96 well plate and were 
allowed to attach overnight. The quantity of GSH was measured in the total number 
of cells after a specific duration in culture, and this was divided by the total number 
of cells in the culture. However, cells multiply after they are seeded, and to 
accurately determine the quantity of GSH per unit cell, a pilot experiment was 
carried out to determine the number of bEnd5 cells after the selected culturing time 
frame. 
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2.4.2 Determination of bEnd5 cells proliferation rate 
 
Cell proliferation is an increase in the number of cells after seeding them because 
of the healthy, normal processes by which cells grow and multiply. Determining 
cellular proliferation rate is necessary to approximate how many cells are in wells 
at a particular time after seeding. Trypan Blue (TB) was used in this experiment to 
count bEnd5 cells to determine bEnd5 cells proliferation. 
Trypan Blue is a carcinogenic dye utilised for staining and identifying non-viable 
cells present in a sample with compromised membranes. This assay differentiates 
between dead and live cells (Strober, 2001). Non-viable cells absorb and retain the 
TB due to their non-selective permeability, whereas viable cells do not absorb the 
dye (Freshney et al., 2006; Mascotti et al., 2000). Non-viable cells were stained 
blue and the viable cells luminesced when viewed using standard light microscopy. 
After a cell count, 1x10 6 cells were seeded into 25 cm2 flasks in groups of five 
(n=3; day=0). Cells were incubated at 37°C and 5% CO2. After the respective time 
intervals of the incubation bEnd5 cells were washed, trypsinated, centrifuged, 
resuspended in media in preparation to perform the TB staining for cell counting. 
Cells were counted, using the Neubauer hemocytometer after 24, 26, 28, 30 and 32 
hours. The TB cell suspension was made up of 10 μl cells suspension and 10 μl TB. 
The 10 μl of TB cell suspension was added to the particular sections of the 
hemocytometer and was observed under an inverted- phase contrast microscope 
(Zeiss) to determine the total live and dead cells. This process was performed for 
each flask of cells at each time point to obtain a bEnd5 cells growth curve. 
Moreover, the bEnd5 cell doubling time (Td) was determined using the plot of the 
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rate of proliferation against duration of cells in culture. The experiment was 
performed in triplicate. 
 
2.4.3 Quantification of cellular glutathione content using the GSH-GloTM 
Glutathione assay kit 
2.4.3.1 Description for GSH-GloTM Glutathione assay 
 
The GSH-Glo™ Glutathione assay is a luminescence-based assay for detecting and 
quantifying glutathione (GSH). The assay depends on the transition of a luciferin 
derivative (Luc-NT) into luciferin in the presence of glutathione, catalysed by 
glutathione S-transferase (GST) (Scherer et al., 2008) (Fig 2.2). The signal created 
during a coupled reaction with firefly luciferase is proportional to the quantity of 
glutathione present within the sample. Maximal luminescence is achieved in less 
than one hour. This assay (Fig 2.2) is suitable to detect and quantify GSH in cultured 
cells and different biological samples because of the ease with which cells can be 
grown, treated and lysed in the same plate and its generation of stable luminescence 
signal.  
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Figure 2.2: An overview of the GSH-Glo™ Glutathione assay. 
(https://worldwide.promega.com). 
 
2.4.3.2 Chemical requirements and sample handling for the GSH-GloTM 
Glutathione assay 
 
The GSH-GloTM Glutathione assay (Promega) included Luciferin-NT substrate, 
GST, GSH-Glo reaction buffer, 5 mM stock GSH solution, reconstitution buffer 
with esterase, lyophilised Luciferin detection reagent and 1 mM TCEP (Tris (2-
Carboxyethyl) Phosphine) (Sigma C4706) to convert GSSG to GSH. 
 
2.4.3.3 Reagents prepared 
 
GSH-Glo Reagent 1X was prepared by transfer 35 µl of Luciferin-NT substrate, 
and 35 µl of GST and 3.5 ml of GSH-Glo reaction buffer to the Eppendorf tube. 
GSH Standards were prepared by diluting 5 mM stock GSH solution to (1:50). Then 
serial 1:1 dilutions was carried out to obtain a final range between 0 and 5 µM when 
10 µl of each serial dilution product is mixed with 100 µl GSH-Glo reagent and 100 
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µl of luciferin detection reagent in each well. Luciferin detection reagent was 
prepared by transferring an equal volume of reconstituted buffer and esterase to the 
dark bottle of lyophilised Luciferin detection reagent and mixed by inversion until 
the substrate was dissolved. 174.43 mM stock of TCEP solution was prepared by 
dissolved 1 g of TCEP (Sigma C4706) in 20 ml of water and stored at -20ºC, to use 
at a final concentration of 1 mM. 
 
2.4.3.4 Sample preparation 
 
To quantify the content of GSH in bEnd5 cells, 4,000 bEnd5 cells were seeded in 
triplicate wells in columns eight to nine of a 96 well plate as per the instruction of 
the manufacturer. To facilitate referencing of the wells in a 96 well plate, the plate 
was annotated into columns eight to nine and rows A-E. The plate was incubated at 
37°C and 5% CO2 for 24 hours to allow for cell attachment. 10 µl of each diluted 
standard was transferred to triplicate was used wells in columns one to seven, of the 
same plate (preparing for final concentrations 5, 2.5, 1.25, 0.625, 0.3125, 0.15625 
and 0.078 µM GSH). The culture medium was carefully removed from the cell-
containing wells, and 100 µl of prepared 1X GSH-Glo reagent transferred to each 
well. Then 100 µl of 1 mM TCEP reagent were transferred to bEnd5 cells which 
were cultured in wells A-D in column nine. The plate was mixed briefly on a plate 
shaker and incubated at room temperature for 30 minutes. Of the reconstituted 
Luciferin detection reagent, 100 µl was transferred to each well, and the plate 
briefly mixed on a plate shaker. The plate was then incubated at room temperature 
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for 15 minutes, and luminescence was read using a GloMax–Multi Detection 
System (Promega).  
Luminescence readings (in RLU) were converted to GSH concentration using the 
GSH standard curve obtained from readings in columns one to seven. 
Luminescence readings from column eight was divided by 10,000 to obtain the 
amount of GSH per cell. And total glutathione concentration obtained from 
readings in column nine was divided by 10,000 according to the bEnd5 cells 
proliferation rate to obtain the amount of total glutathione (GSHT) per cell. The 
amount of (GSSG) glutathione per cell was derived from the difference between 
the GSHT and GSH values. The values of GSH and GSSG was used to determine 
the GSH/GSSG ratio for the bEnd5 cells. 
 
2.5 Determination of the ROS neutralising capacity of bEnd5 cells  
 
To determine the GSH-mediated ROS neutralising capacity of bEnd5 cells, the 
GSH-GloTM Glutathione assay was used to relatively quantify and compare cellular 
GSH levels following treatment with increasing concentrations of H2O2. 
 
2.5.1 Chemical requirements and sample handling for the determination of 
the ROS neutralising capacity of bEnd5 cells 
 
The following stock solutions were used in the determination of the ROS 
neutralising capacity of bEnd5 cells. This included H2O2 that was serially diluted 
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into concentrations of 0.5, 1.0, 1.5, 2.0, 2.5, 5.0 mM and 50, 100, 150, 200, 250 and 
500 µM. (See Appendix). Luciferin-NT substrate, GST, GSH-Glo reaction buffer, 
5 mM stock GSH solution, reconstitution buffer with esterase, lyophilised Luciferin 
detection reagent and 1 mM TCEP (Sigma C4706) to convert GSSG to GSH were 
prepared as previously described (see Section 3.5.3.3).  
 
2.5.2 Sample treatment with 0-5000 µM of H2O2 
 
The bEnd5 cells were seeded in 96 well plates at a density of 4,000 cells per well. 
Cells were incubated overnight at 37°C and 5% CO2 to allow for attachment after 
which the culture medium in each well was aspirated. Cells were treated in 12 
columns of a 96-well plate using duplicate of four wells for each treatment group. 
They were treated with supplemented DMEM medium dosed with increasing 
concentrations (50, 100, 150, 200, 250, 500, 1000, 1500, 2000, 2500, 5000 µM) of 
H2O2 or supplemented DMEM alone (medium). An untreated set of four wells 
served as control (Fig 2.3). These experiments were set up in two 96 well plates 
with different duration of treatment lasting 24 and 48 hours for the different plates.  
Following treatment for a specified time interval, cells in each well were viewed 
and imaged under an inverted-phase microscope, then growth media were removed, 
and 100 µl of prepared 1X GSH-Glo reagent was transferred to each well. Then 
100 µl of 1 mM TCEP reagent was transferred to one column of each duplicate 
concentration, to convert the GSSG to GSH. The plate was mixed briefly on a plate 
shaker and incubated at room temperature for 30 minutes.  
http://etd.uwc.ac.za
48 
 
Of the reconstituted Luciferin detection reagent, 100 µl was transferred to each 
well, and the plate was mixed briefly on a plate shaker. The samples were incubated 
at room temperature for 15 minutes, and luminescence was read using a GloMax–
Multi Detection System (Promega). Luminescence readings (in RLU) were 
converted to GSH concentration using the GSH standard curve. The GSHT 
concentrations were obtained from readings in columns with TCEP. The amount of 
GSSG was derived from the difference between the GSHT and GSH values. The 
values of GSH and GSSG were used to determine the GSH/GSSG ratio for the 
bEnd5 cell. 
 
 
Figure 2.3: Treated cells in duplicate columns with supplemented DMEM medium dosed 
with increasing concentrations (50, 100, 150, 200, 250, 500, 1000, 1500, 2000, 2500, 
5000 µM) of H2O2 or supplemented DMEM alone (medium) 
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2.6 Protective effect of Trolox against H2O2 toxicity and GSH depletion 
 
Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-Carboxylic Acid) (Fig 2.3) is a 
hydrophilic synthetic analog of vitamin E and a direct scavenger of alkoxyl radicals 
and peroxyl (Monticone et al., 2014). In vivo and in vitro studies have reported on 
its protective effects against oxidative damages, especially against lipid 
peroxidation in (Lee et al., 2005). 
                                
Figure 2.4: The molecular structure of Trolox (http://www.lookchem.com/Trolox-
C/) 
 
2.6.1 Chemical requirements and sample handling for the protective effect of 
Trolox against H2O2 toxicity and GSH depletion 
 
A 100 mM Trolox solution was prepared. Of this, 25 µM of Trolox was prepared 
in combination with increasing concentrations of H2O2 50, 100, 150, 200, 250, 500, 
1000, 1500, 2000, 2500, and 5000 µM (11 experiment. groups) (See Appendix). 
Luciferin-NT substrate, GST, GSH-Glo reaction buffer, 5 mM stock GSH solution, 
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reconstitution buffer with esterase, lyophilised Luciferin detection reagent and 
1 mM TCEP (Sigma C4706) to convert GSSG to GSH was prepared as previously 
described (see Section 3.5.3.3).  
 
 2.6.2 Treatment with combinations of Trolox and H2O2 
 
The bEnd5 cells were seeded in 96 well plates at a density of 4,000 cells per well. 
Cells were incubated overnight at 37°C and 5% CO2 to allow for attachment after 
which the culture medium in each well was aspirated. Cells in plates were then 
treated with a medium containing 25 µM Trolox in combination with increasing 
concentrations of H2O2 (50 to 5000 µM) (11 expermint. groups) or increasing 
concentrations 50 to 5000 µM for the control groups (11 groups). Both groups of 
cells were incubated for 24 hours, and then in the different groups , the exposure to 
H2O2 was repeated for a duration of 48 hours.  
Following treatment for a specified time interval, cells in each well were viewed 
and imaged under an inverted-phase microscope, then growth media were removed, 
and 100 µl of prepared 1X GSH-Glo reagent was transferred to each well. The plate 
was mixed briefly on a plate shaker and incubated at room temperature for 30 
minutes. Of the reconstituted Luciferin detection reagent, 100 µl was transferred to 
each well, and the plate was mixed briefly on a plate shaker. Then it was incubated 
at room temperature for 15 minutes, and luminescence read using a GloMax–Multi 
Detection System (Promega).  
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Luminescence readings (in RLU) were converted to GSH concentration using the 
GSH standard curve. The GSHT concentration was obtained from readings in 
columns with TCEP. The amount of GSSG was derived from the difference 
between the GSHT and GSH values. The values of GSH and GSSG was used to 
determine the GSH/GSSG ratio for the bEnd5 cell. The experiments were carried 
out in triplicate. 
 
2.7 Statistical analysis  
 
Results were expressed as the mean±SEM. GraphPad Prism (version 6.1) was used 
to analyse the data statistically. Significant differences between groups were 
determined by using the Holm-Sidak method for independent (unpaired) samples. 
A probability of P <0.05 designated statistical significance and four samples were 
used in each treatment group (n=4) with each experiment done in triplicate unless 
otherwise stated.  
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CHAPTER THREE 
Results 
 
GSH is one of the most abundant naturally occurring thiol-based AO within 
mammalian cells. In the literature, it is reported to play a pivotal role in the cellular 
mitigation of OS among other functions such as redox signalling and oxidation-
reduction reactions in metabolic pathways. The presence and concentration of GSH 
in BECs and in immortalised BECs used for studies of the in vitro BBB model have 
not been reported in the literature. Furthermore, the capacity of BECs to respond to 
OS and its relationship to cellular GSH content has not been investigated. 
 
3.1 Monochlorobimane (mBCl) fluorescence 
 
A monochlorobimane fluorescence microscopy assay was utilised to detect and 
localise GSH while fluorometric method using mBCl fluorescence was used to 
relatively quantify GSH in bEnd5 cells. Observation of a blue fluorescence from 
the cells was indicative of the presence of GSH which form a fluorescent GS-
bimane adduct with mBCl. The intensity of the fluorescence observed correlate 
with amount of GSH in the cells (Fig 3.1 B-D). The control samples which were 
not treated with mBCl did not show blue fluorescence (Fig 3.1 A). The variable 
fluorescence intensity observed in the cells indicated a variable concentration of 
intracellular GSH content in the cells. GSH was found to be distributed throughout 
the cytoplasm and nuclear compartments of the cells. Also, the dendritic extensions 
of cells all contained GSH. However, higher magnification (X120) showed that 
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GSH was more concentrated in the nucleus than the cytoplasm part (Fig 3.1 D). 
Furthermore, the entire nucleus had the highest fluorescence which indicated the 
highest localisation of GSH. 
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Figure 3.1 A-D: The above are fluorescent micrographs of bEnd5 cultures exposed to 60 
µM mBCl. Fig A (X 40), the control group, was not exposed to mBCl. Fig B (X 40), the 
60 µM mBCl group, shows fluorescence in all cells. The variable fluorescence between 
cells shows they contained different concentrations of GSH. Fig C, the higher 
magnification (X60), endorsed the varied concentration of GSH per endothelial cell. Fig 
D, the highest magnification (X120) shows two cells with varied fluorescence indicating 
the different concentrations of GSH within the two cells. N: represents the high 
localisation of GSH in the nucleus. 
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3.2 Rat-tail collagen and bEnd5 cells attachment 
 
Slides were coated with rat-tail collagen (10 µg per ml) to improve the bEnd5 cells’ 
adherence to slide surface and mimic an in vivo BM. This allowed the bEnd5 cells 
to physiologically and functionally orientate themselves regarding their apico-
lateral and baso-lateral morphology.  
Images obtained from the mBCl treated group showed blue fluorescence within the 
cells which localised the fluorescent GS-bimane adduct. While the images obtained 
from the control groups showed no fluorescence (Fig 3.2 A and C). Images for the 
second group (Fig 3.2 D), which was coated with rat-tail collagen, showed a higher 
number of bEnd5 cells attached to the slides than the first group which was not 
coated with collagen (Fig 3.2 B). This indicates that rat-tail collagen facilitated 
bEnd5 cell division and attachment to the slides.  
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Figure 3.2 A-D: The above fluorescent micrographs show images of bEnd5 cultures 
exposed to 60 µM mBCl. Cells seeded on glass slides for the two groups: uncoated and 
coated with rat-tail collagen (Fig D collagen-coated group, and Fig B, uncoated group (X 
40)). Figs A and C (control groups) were not treated with mBCl (X 40). B: the 60 µM mBCl 
uncoated group shows a lower number of bEnd5 cell attachment to the slide. C: the control 
group coated with rat-tail collagen. D: the 60 µM mBCl coated group showing a higher 
number of bEnd5 cells attached to the slide. 
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3.3 bEnd5 cells proliferation rate 
 
To accurately determine the number of cells after they had been cultured for a 
defined period, it was crucial to determine the quantity of GSH per cell accurately. 
The data, obtained over 35 hours are shown in Fig 3.3. Linear regression analysis 
indicated that the sloping line (rate of cell division) between 0 min and 24 hours 
and between 24 and 35 hours revealed the doubling time of cells as 15.66 hours 
over 24 hours, with 11 hours after that depicting the bEnd5 cell-growth curve. 
 
 
 
 
Figure 3.3: The bEnd5 cell-growth curve. The time of bEnd5 cells to double in culture 
over 24 hours is extrapolated in the graph to 15 hours 40 minutes. however, the slope of 
the graph changed after 24 hours to indicate an increased rate of cell division, with a 
doubling time of 11 hours between 24 and 35 hours. The experiment was done in 
triplicate.  
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3.4 Quantity of glutathione in bEnd5 cell 
 
We also estimated the average basal quantity of GSH in a single bEnd5 cell using 
a GSH-Glo assay kit which utilises a luminescence method allowing for the 
quantification of GSH in 96 well plates. The redox status of the cell was 
investigated with respect to the GSH:GSSG ratio by using the GSH-Glo kit to 
quantify the amount of GSH per endothelial cell. We determined the basal 
GSH:GSSG status of the cells between 24 and 96 hours in culture to determine the 
effect of proliferation in culture on the basal redox status of the cells. The GSH-Glo 
kit does not allow the direct measurement of the GSSG fraction of the GSHT.  
We addressed this by recycling GSSG using 500 µM TCEP, to convert it to GSH, 
which then allows for the determination of the total amount of glutathione per cell. 
The concentration of GSSG per cell was quantified by subtracting the initial GSH 
concentration from the GSHT concentration (GSH + GSH reduced from GSSG) 
(modification of the method of Tietze, 1969). 
The analysis involved generating a glutathione standard curve according to the 
GSH-Glo™ Glutathione Assay Technical Bulletin #TB369. Briefly, this entailed 
serial dilutions of a 5 mM stock solution of glutathione in PBS (range 0–5 µM). 
GSH concentrations were calculated based on the GSH standard curve (Fig 3.4).  
In subsequent calculations, we found that the approximate GSH concentration in 
each bEnd5 cell was 0.031±0.00035 nM, while the GSSG concentration was 
approximately 0.00092±0.00021 nM. Most of intracellular glutathione in bEnd5 
cells was found in its reduced form where 97% of the glutathione pool is of reduced 
form (GSH) while 3% exists in the GSSG form (Fig 3.5).  
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Figure 3.4: The GSH standard curve presented a linear correlation between the 
relative luminescence units (RLU) and the GSH concentration, with a r2 value 
˃0.9987. 
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Figure 3.5: The ratio of GSH/GSSG in bEnd5 cells at 24, 48, 72 and 96 hours. The 
pie chart represents the GSH:GSSG ratio, in untreated bEnd5 cells which ranged 
between 99:1 and 94:6 over 96 hours. The bEnd5 cells showed an average 97% of 
the total glutathione pool in the reduced form (GSH) with 3% in the GSSG form. 
 
3.5 ROS neutralising capacity of bEnd5 cells over 24 hours 
 
3.5.1 GSH changes 
 
GSH is one of the predominant intracellular AO used to neutralise cellular derived 
H2O2 (Fig 3.6). The possible ROS neutralising capacity was determined by treating 
bEnd5 cells with increasing concentrations of H2O2 (50-2500 µM) and measuring 
the relative concentrations of GSHT and GSH over 24 hours. The assay enabled the 
measurement of the GSHT and GSH. GSHT represented the combined concentration 
of GSH and GSSG in the cells (Fig 3.6). Thus, GSSG was determined indirectly as 
the difference between GSHT and GSH. (Chapter 2 p 49). 
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Figure 3.6:  The above reaction represents the reduction of H2O2 by GSH and its 
subsequent conversion to GSSG and H2O. The reaction is catalysed by glutathione 
peroxidase (Gpx). 
 
H2O2 treatment was expected to reduce cellular GSH concentration because of its 
role in reducing H2O2 to H2O through the oxidation of GSH to GSSG by Gpx (Fig 
3.6). 
Treatment of bEnd5 cultures with 50 to 150 µM H2O2 over 24 hours showed a 
significant increase (an average 34.89%) in GSHT relative to control GSHT 
concentrations (P <0.05). GSHT were significantly (P <0.05) elevated between 50 
and 500 µM H2O2 and significantly depressed between 1500 and 2500 µM H2O2 
compared to the untreated bEnd5 cell Control group (Fig 3.7). 
Several observations were surprising (Fig 3.7). First, the cellular level of GSH 
increased by (25.38 %) after treatment with 50 and 150 µM H2O2 relative to control. 
The cultures exposed to 250 and 500 µM H2O2, GSH concentrations showed a 
decrease of 8.79% to a new but stable level compared to the 150 µM H2O2. 
However, 1500 and 2500 µM H2O2 GSH dropped by 71.14% compared to the 
500 µM H2O2.  
Second, GSSG increased from the control level by 144.58% at 50 µM H2O2. At 150 
and 500 µM H2O2, GSSG increased by an average of 39.57% to a new but constant 
level. At the doses of 1500 µM and 2500 µM H2O2, GSSG levels further increased 
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by an average of 77.05% compared to the 500 µM H2O2 and remained statistically 
constant across these treatments of H2O2.  
Third, a dose-dependent decrease in GSHT to a new level which remained sustained 
was then observed at 1500 and 2500 µM H2O2 compared to the 500 µM H2O2. 
GSHT reflected the levels of intracellular GSH throughout the experiment (Fig 3.7). 
The latter drop in GSHT at high levels of H2O2 and could be attributed to the 
decrease in GSH RLU because of the decline in cell numbers. 
The average GSH:GSSG ratio at 50 and 500 µM H2O2 was 13:87 and the average 
GSH:GSSG ratio at 1500 and 2500 µM H2O2 was 48:52. 
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Figure 3.7: Relative reduced glutathione (GSH), glutathione disulphide (GSSG) and total 
glutathione (GSHT) levels in bEnd5 cells following incubation with H2O2 over 24 hours. 
Control bEnd5 cells were incubated for 24 hours without any addition of H2O2, while other 
bEnd5 cells were treated with increasing concentrations of H2O2 (50 to 2500 µM) before 
determining the levels of GSH, GSSH, and GSHT. The asterisk (*) denotes statistically 
significant differences between control GSHT and H2O2 treated cells; the hash (#) denotes 
statistically significant differences between the GSH control and H2O2 treated group of 
bEnd5 cells; while the bullet (●) denotes statistically significant differences between 
control GSSG and the H2O2 treated groups of bEnd5 cells. The @ denotes that at high levels 
of H2O2 treatment (1500-2500 µM). Although the high levels of oxidative stress (OS) 
caused cells to begin to die, they were still not able to access available GSH. Data are 
represented as means ± SEM (n=4). Statistical significance at level P <0.05 was determined 
(see Appendix B). The experiment was performed three times.  
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Figure 3.8: The data show a trend in relative cellular GSHT, GSH and GSSG content of 
bEnd5 cells exposed to varying concentrations of H2O2 over 24 hours using a linear 
horizontal axis. A steep and maximal rise in the GSH was observed from 50 to 150 µM 
H2O2 which decreased at a concentration of 250-2500 µM H2O2. At the extrapolated H2O2 
concentration of 1400 µM (see arrow), the reduced GSH and oxidised glutathione (GSSG) 
concentrations equalised. This point indicates the level of OS (H2O2) from which the cells 
appeared to change shape and enter a necrotic phase. GSH linearly decreased in 
concentration between 50 and 1500 µM H2O2 and then remained constant. GSSG linearly 
increased in concentration between 50 and 1500 µM and then remained statistically 
constant. Between 1500 µM and 2500 µM of H2O2, GSH and GSSG concentrations did not 
statistically change, and the decreases of GSHT reflected the decreases of GSH.  
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3.5.2 GSH/GSSG ratio in bEnd5 cells after being treated with H2O2 
 
Figure 3.9: The ratio of GSH:GSSG in bEnd5 cells after being treated with increasing 
concentrations of H2O2 (50-2500 µM) over 24 hours. The diameter of the pie chart 
represents the GSHT which increases and remains stable after treatment with 50-500 µM 
H2O2. However, it decreases with 1500-2500 µM H2O2 after treatment. The ratio of 
GSH:GSGS <1 between 1500 and 2500 µM in Fig 3.8, shows that at 1400 µM H2O2 the 
GSH:GSSG ratio is <1. 
 
3.5.3 Cell growth changes at 24 hours 
 
After treatment with increasing concentrations of the H2O2 (50-5000 μM) for 24 
hours, the bEnd5 cells were observed and recorded. No observable cell growth and 
size changes in bEnd5 cells occurred between the control and exposed groups 
between 50-500 μM H2O2. Only at higher concentrations of H2O2 (1-5 mM) did 
cells appear to be smaller and less observable (Fig 3.10 H-L).  
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Figure 3.10 A-L: Observed bEnd5 cell growth at X 40 after being treated with increasing 
concentrations of H2O2 (0-5 mM) over 24 hours. Growth remained unchanged after treated 
with 0-500 µM H2O2. All higher concentrations (1-5 mM) showed a change in the cell 
growth (H-L). 
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3.6 ROS neutralising capacity of bEnd5 cells over 48 hours 
  
3.6.1 GSH changes 
 
The treatment of another group of cells was allowed to proceed for 48 hours to 
investigate if prolonged exposure to H2O2 would affect cellular concentrations of 
GSH/GSSG. Treated cells were exposed with H2O2 for 24 hours after which media 
were aspirated and replaced with fresh H2O2-dosed media and allowed to incubate 
for a further 24 hours. Doses of H2O2 (between 50 µM and 500 µM) continued over 
48 hours to significantly elevate the levels of GSHT. 
Several observations were surprising. First, at 50 µM H2O2, GSH increased 
significantly compared to that of the control, then the GSH level decreased after 
treatment with 150, 250 and 500 µM H2O2. Second, at a dose of 1500 and 2500 µM 
H2O2, the GSHT concentration dropped and remained statistically constant. 
However, at 1500 and 2500 µM H2O2 the GSH level decreased to a new (RLU <0.5 
x 106) but relatively stable level, which did not differ statistically. Third, GSSG 
increased at 50 µM H2O2 compared to the control (P < 0.0001). The GSSG level 
increased to a new stable level at 150 and 250 µM H2O2, and then decreased and 
remained statistically constant at 1500 and 2500 µM H2O2 (Fig 3.11). 
GSHT reflected the levels of intracellular GSH throughout the experiment (Fig 
3.11). The drop in GSHT at 1500 and 2500 µM could be ascribed to a possible 
decrease in cell number (Fig 3.14). 
The GSH to GSSG ratio at 50, 150, 250, 500 µM H2O2 was 75:25, which changed 
dramatically at 1500-2500 µM H2O2 to 51:49. 
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Figure 3.11: GSH, GSSG and GSHT levels in bEnd5 cells following incubation with H2O2 
over 48 hours. The bEnd5 cells were incubated with increasing concentrations of H2O2 (50 
µM to 2500 µM) before determining the levels of GSH, GSSH and GSHT. The asterisk (*) 
denoted statistically significant differences between the control and experimental GSHT 
concentrations, and the hash (#) denoted statistically significant differences between the 
control and experimental GSH levels, while the bullet (●) denoted statistically significant 
differences in GSSG levels in bEnd5 cells between the experimental samples relative to 
controls. The @ denotes high levels of H2O2 treatment (1500 and 2500 µM), although GSH 
was still present in the cells, it appeared inaccessible and was not available to further protect 
the cells against the ravages of OS. 
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Figure 3.12: The above graph uses trend lines to depict changes in cellular glutathione 
content of bEnd5 cells exposed to varying concentrations of H2O2 over 48 hours. Between 
50 and 100 µM H2O2 resulted in a steep and maximal rise in the GSHT, which then decreased 
and plateaued at 1500-2500 µM H2O2. A similar decrease in GSH mirrored the GSHT 
decrease. At H2O2 concentrations of 1500 µM (see arrow) reduced GSH and oxidised 
glutathione GSSG concentrations equalised. This point indicates the level of OS (H2O2) at 
which the cell numbers visible appeared to decrease. GSH maximally increased in 
concentration from 0-50 µM H2O2 which thereafter decreased in cells exposed to 1500 µM 
H2O2 and plateaued at 2500 µM H2O2. During 0-100 µM H2O2 exposure, GSSG increased 
maximally at 100 µM H2O2 and then plateaued at 2500 µM H2O2. 
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3.6.2 H2O2 treated cells at 48 hours 
 
The ratio of GSH/GSSG in bEnd5 cells was found to increase after treatment with 
increasing concentrations of H2O2 (50-2500 µM) over 48 hours. The GSH:GSSG 
ratio was >1 for five of seven experimental treatment groups, while it was <1 in the 
other two groups indicating that bEnd5 cells were under OS (Fig 3.13). 
 
 
 
Figure 3.13: The longitudinal diameter of the pie charts reflects the relative GSHT in bEnd5 
cells. The pie chart also indicates the GSH:GSSG ratio in bEnd5 cells after being treated 
with increasing concentrations of H2O2 groups (50-2500 µM) over 48 hours. Except for 
1500 and 2500 µM H2O2, the GSH:GSSG ratio of all the other groups was >1. Ratios of <1 
typifies cellular population in redox stress. 
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3.6.3 Cell growth changes at 48 hours 
 
After being exposed to increasing concentrations of the H2O2 (0-5 mM) over 48 
hours, bEnd5 cell growth was observed with an inverted microscope (Zeiss) (Fig 
3.14). No observable changes in the bEnd5 cell growth were noted between the 
control and the experimental groups of 50-500 µM (Fig 3.14 A-G). At higher 
concentrations (1-5 mM) cells became fewer and smaller than usual (Fig 3.14 H-
L). 
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Figure 3.14 A-L: Micrographs at X 40 show bEnd5 cells after being exposed to 
increasing concentrations of H2O2 (0-5 mM) over 48 hours. No observable 
difference is seen until 500 µM (A-G). At higher concentration (1000-5000 µM) 
fewer cells were observed (H-L).  
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3.7 Protective effect of Trolox against H2O2 toxicity and GSH depletion over 
24 hours 
 
3.7.1 GSH changes 
 
In view of the evidence in the literature, it was postulated that Trolox would 
alleviate the effects of H2O2. Therefore, the effects of the combinations of H2O2 and 
Trolox on the bEnd5 cells were investigated. The effect of the increasing 
concentrations of H2O2 (50-2500 µM) alone (control) was compared with the 
combined effect of the increasing concentrations of H2O2 (50-2500 µM) with 25 
µM Trolox (test) for 24 hours. Simultaneous treatment of cells with H2O2 and 
Trolox was observed to have no effect on the GSHT - GSH - GSSG profile (P >0.05) 
in response to H2O2 treatment. 
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Figure 3.15: Shows changes in the GSH level in bEnd5 cells following incubation with 
increasing concentrations of H2O2 alone or in combination with 25 µM Trolox for a 24-
hour exposure period. bEnd5 cells were incubated for 24 hours in supplemented DMEM 
medium dosed with increasing concentrations of H2O2 (50-2500 µM) alone (control 
groups) or combined with 25 µM of Trolox treated groups before determining the GSHT 
level. The ‘T’ denotes the addition of 25 µM Trolox to the selected concentrations of H2O2. 
The data show there were no statistically significant differences in GSHT, GSH and GSSG 
levels between cells exposed to H2O2 alone and those with added Trolox, P >0.05 (see 
Appendix E). The @ denotes that high levels of H2O2 treatment (1500-2500 µM) cells 
begin to die, yet were not able to access available GSH present in the cytoplasm.  
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3.7.2 Cell growth changes: Effect of Trolox 
 
The bEnd5 cell growth was observed and recorded after being exposed to increasing 
concentrations of the H2O2 (50 µM-5 mM) or in combination with 25 µM Trolox 
over a 24 hour period (Fig 3.16). There was no observable difference between the 
cells exposed to H2O2 (50-500 µM) (Figs 3.16 A and C) and those that were exposed 
to both (50-500 µM) H2O2 and 25 µM Trolox (Figs 3.16 B and D). 
There was a distinct difference observed between cells exposed to 1 mM H2O2 and 
those that were exposed to both 1 mM H2O2 and 25 µM Trolox (Figs 3.16 E & F). 
The cells became fewer and smaller (Fig 3.16 E). While in Fig 3.16, the cells 
exposed to both 1 mM H2O2 and Trolox appeared viable and healthy. There was no 
distinct difference observed between cells exposed to H2O2 at 5 mM and those that 
were exposed to both 5 mM H2O2 and 25 µM Trolox. Here both sets of cells became 
fewer and smaller (Figs 3.16 G & H). In general, cells exposed to Trolox exhibited 
a healthier appearance and appeared to have a pronounced protective effect against 
the OS effects of H2O2. 
. 
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Figure 3.16 A-H: Exposure of bEnd5 cell growth to increasing concentrations of the H2O2 
(50 µM-5 mM) alone or combined with 25 µM Trolox over 24 hours. Micrographs A and 
C represent cells exposed to 50 µM-500 µM H2O2, and B and D represent cells exposed to 
both H2O2 and 25 µM Trolox. In micrographs E-F there were distinct differences observed 
between cells exposed to 1 mM H2O2, where cells appeared fewer and small, but those that 
were exposed to both 1 mM H2O2 and 25 µM Trolox appeared viable and healthy. Cells 
exposed to 5 mM H2O2 were fewer and smaller (G), and the affect of Trolox did not protect 
the cells (H). 
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3.8 Protective effect of Trolox against H2O2 toxicity and GSH depletion over 
48 hours 
3.8.1 GSH changes 
 
Extending the above study (Protective effect of Trolox against H2O2 toxicity and 
GSH depletion over 24 hours), the effect of the increasing concentrations of H2O2 
(50-2500 µM) alone (control) was compared with the combined effect of the 
increasing concentrations of H2O2 (50-2500 µM) with 25 µM Trolox (test) for 48 
hours. When evaluating the combination of increasing concentrations of H2O2 and 
25 µM Trolox for 48 hours, the previously described GSHT, GSH and GSSG profile 
for H2O2 treatment on bEnd5 cells was repeated. The data confirmed that treatment 
with Trolox and H2O2 had no effect on the GSHT - GSH - GSSG profile. 
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Figure 3.17: Changes in GSH level in bEnd5 cells following incubation with 
increasing concentrations of H2O2 alone or a combination of increasing 
concentrations of H2O2 and 25 µM Trolox for 48 hours are shown. bEnd5 cells were 
exposed to increasing concentrations of H2O2 (50-2500 µM) alone (control groups) 
or combined with 25 µM Trolox (treated groups) before determining the levels of 
GSH. The 'T' denotes the combination of increasing concentrations of H2O2 and 25 
µM Trolox. The data showed there were no statistically significant differences in 
GSHT, GSH and GSSG levels in bEnd5 cells between the experimental samples and 
controls (P >0.05) (see Appendix F). The @ denotes that high levels of H2O2 
treatment (1500-2500 µM) cells begin to die, yet were not able to access available 
GSH present in the cytoplasm. 
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3.8.2 The effect of Trolox and H2O2 on cell growth over 48 hours 
 
The bEnd5 cell growth was observed and recorded after being exposed to increasing 
concentrations of the H2O2 alone (50 µM-5 mM) or H2O2 (50 µM-5 mM) combined 
with 25 µM Trolox after a 48 hour exposure period (Fig 3.18). There was no 
observable difference between cells exposed to H2O2 (50-500 µM) (Fig 3.18 A and 
C) and the cells that were exposed to both (50-500 µM) H2O2 and 25 µM Trolox 
(Fig 3.18 B and D). There was a distinct difference observed between cells exposed 
to 1 mM H2O2 and those that were exposed to 1 mM H2O2 and 25 µM Trolox (Fig 
3.18 E and F). Micrograph E represented the effect seen throughout the experiment 
with smaller and fewer cells between 1 mM-5 mM H2O2 (Fig 3.18 E), while Fig 
3.18 F, the protective effects of Trolox are shown. However, there was no distinct 
difference observed between cells exposed to 5 mM H2O2 and those that were 
exposed to 5 mM H2O2 and 25 µM Trolox (Fig 3.18 G and H), which represented 
the effects seen throughout the experiment, presenting a decreased number of cells 
that were smaller than control cells. 
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Figure 3.18 A-H: The effects of increasing concentrations of the H2O2 (50-5000 µM) alone 
or combined with 25 µM Trolox over a 48 hours exposure period. Micrographs X 80 A and 
C represent cells exposed to 50-500 µM, and micrographs B and D represent those cells 
exposed to both H2O2 and 25 µM Trolox. There was no observable difference between cells 
exposed to H2O2 (50-500 µM) and those that were exposed to both 50-500 µM H2O2 and 
25 µM Trolox. Micrographs E and F show a distinct difference observed between cells 
exposed to 1 mM H2O2 (E) and those that were exposed to both 1 mM H2O2 and 25 µM 
Trolox (F), while E represents the effect seen throughout the experiment with smaller and  
fewer cells between 1 mM and 5 mM H2O2 Micrograph F showed that Trolox protects the 
cells against OS. There was no distinct difference observed between cells exposed to 5 mM 
H2O2 (G) and those that were exposed to both 5 mM H2O2 and 25 µM Trolox (H). In 
micrograph H the effect seen throughout the experiment shows smaller and fewer cells. 
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CHAPTER FOUR 
Discussion 
4.1 Introduction 
 
The BBB is a structural and metabolic partition between the CNS and the peripheral 
blood circulation, which regulates the fluxes of molecules and cells en route to the 
CNS from the blood and vice versa (Huber et al., 2001). Thus, it is crucial to the 
maintenance of CNS homeostasis. Complex interactions between many cell types 
form the BBB, which is a dynamic interface capable of reactive responses to signals 
within the blood circulation and the CNS (Huber et al., 2001).  
Primarily, the cell types include a monolayer of brain capillary endothelial cells as 
an interface with the blood and a perivascular set of cells on the brain side of 
microvessels, the astrocytes and pericytes (Abbott et al., 2010). The primary 
function of the BBB is to keep the brain parenchyma undisturbed by changes in the 
plasma composition, as can occur following meals or exercise, and to protect from 
xenobiotics that are capable of altering neural functions. Also, to protect against 
peripherally circulating substances with neurotransmitter capabilities (Abbott et al., 
2010).  
The mechanical barrier is characterised by a lack of fenestrations in the endothelial 
junctions and very low rate of transcytosis (Wolburg & Lippoldt, 2002). 
Furthermore, the TJ between them is stronger than any endothelial TJ found 
elsewhere in the body as evidenced by its P-face strand association in freeze-
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fracture replica electron microscopic studies (Wolburg & Lippoldt, 2002). This 
serves to restrict the paracellular diffusion of hydrophilic solutes such that only 
small molecules such as O2, CO2, and small lipophilic molecules (e.g., 
methamphetamine and alcohol) can freely diffuse across the lipid membranes of the 
endothelium (Fisher et al., 2015).  
The BBB acts as a metabolic interface which contains specific carriers for essential 
molecules, such as the glucose transporter GLUT-1 occurring on both the luminal 
and abluminal membranes of the endothelial cells (Abbott et al., 2010). Another 
example of the role of the BBB is the P-glycoprotein transporter expressed on the 
endothelial luminal surface which protects the brain from xenobiotics and the 
potentially excitotoxic glutamate (Li et al., 2012). Furthermore, the presence of 
endothelial degradation enzymes, such as peptidases and nucleotidases, which 
metabolise peptides and ATP, respectively, and the intracellular enzymes 
monoamine oxidase and cytochrome P450 1A and 2B which inactivate blood-borne 
neuroactive compounds (Li et al., 2012) provide an enzymatic barrier. Thus, 
multiple functions of the BBB regulate the brain microenvironment to ensure 
homeostatic balance.  
Involvement of the BBB has been implicated in the development and propagation 
of several neuropathological conditions (Gilgun-Sherkiet et al., 2001). Hypoxic-
ischemic disorders such as stroke, neurodegenerative disorders such as Parkinson’s 
disease, Alzheimer’s disease and multiple sclerosis have all been invariably linked 
to the compromise in the integrity of the BBB (Deane & Zlokovic, 2007; Stolp & 
Dziegielewska, 2009). Furthermore, many of the conditions leading to BBB 
dysfunction do so by way of inducing oxidative stress either within cells of the BBB 
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or tissues in the BBB microenvironment. On this basis, several clinical trials have 
been sanctioned to investigate the rational use of antioxidants in alleviating several 
neurological diseases (Moosmann & Behl, 2002; Rao & Balachandran, 2002). 
Therefore, it was judicious to investigate how the BBB endothelial cells respond to 
OS and in particular look at the role of GSH, a naturally occurring intracellular 
antioxidant. As we were using an immortalised brain endothelial cell-line, bEnd5, 
we first had to establish whether GSH actually exists within the cell-line of study 
before investigating its physiological role in the BBB further.  
 
4.2 Glutathione profile of bEnd5 cell line 
 
In this study, we profiled, for the first time, the GSH content at the brain endothelial 
cell using the bEnd5 cell as a model to gauge the capacity of its innate GSH content 
to reactively neutralise ROS presented in the form of hydrogen peroxide. ROS is a 
known cause of BBB dysfunction (Lehner et al., 2011), while GSH is an important 
cellular antioxidant (Lu, 2009).  
Although bEnd5 cells are routinely used in the experimental modelling of the BBB 
(Steiner et al.,2011), information regarding its antioxidant capacity has not been 
previously reported in scientific literature. Our objectives, therefore, were first to 
demonstrate the presence of GSH in bEnd5 cells, estimate the quantity of this 
important antioxidant in a single endothelial cell (bEnd5) and determine the 
capacity of these cells in culture to neutralise OS (H2O2) and thereby protecting the 
cell from oxidative damage. Lastly, the impact of exogenous AOs and its impact on 
the endogenous GSH AO capacity of the bEnd5 cell was studied. 
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4.2.1 Detection of glutathione in bEnd5 endothelial cell line 
 
The presence of GSH in bEnd5 cells was demonstrated by using a cell-permeable 
fluorochrome, mBCl. This compound has the ability to combine with thiol groups 
to form a fluorescent bimane adduct which can be detected and quantified 
fluorometrically. However, many of the bimane compounds bind with thiol groups 
in cellular proteins thereby contributing to the intensity of detected fluorescence 
and, therefore, is not specific for GSH.  
Our choice of mBCl in this study was based on its specificity for the thiol group in 
GSH with negligible binding to protein thiols (Chatterjee et al., 1999). Ordinarily, 
mBCl alone does not fluoresce, but when in combination with the thiol group of 
GSH, it is converted to a fluorescent molecule that can be viewed under a 
fluorescent microscope. Cells that were incubated with 60 µM mBCl showed blue 
fluorescence, while untreated control experimental cells without mBCl showed no 
fluorescence (Fig 3.1 A and B). This confirmed that the observed fluorescence was 
attributable to the presence of the glutathione-bimane adduct in the mBCl-treated 
cells. The fluorescent intensity observed varied among the cells which suggest 
varying concentrations of GSH in the cellular content.  
Differences in the redox and/or metabolic status of the cells may have imparted the 
differential fluorescent intensities. Furthermore, this observed variation in 
fluorescent intensities among the cultured cells may indicate differences in the 
redox status of individual cells in culture. Also, observed are slight differential 
density in the fluorescence between the nuclear and cytosolic compartments. The 
blue fluorescence observed in the cytosolic compartments showed increased 
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brightness around the nuclear compartments of the cells which suggest higher 
concentrations of GSH in the nuclear compartment of these endothelial cells (Fig 
3.1 C). Also, the higher fluorescence found within the nucleus indicates a higher 
nuclear concentration of GSH than the cytosol. This points to the role of GSH as 
the primary AO protecting DNA against ROS (Fig 3.1 D), which agrees with 
previous reports of intracellular compartmentalisation of GSH distribution (Li et 
al., 2012). 
In culture, bEnd5 cells are adherent cells which proliferate and also grow in size by 
projecting cytoplasmic extensions upon the substratum. This explains why the 
bEnd5 cells showed improved attachment and also with more conspicuous 
cytoplasmic extensions when they were grown on collagen-coated microscopic 
slides. We observed the presence of GSH-induced fluorescence in every strand of 
cytoplasmic extension, an observation which further underscores the antioxidative 
importance of GSH in every segment of the cells for their viability (Fig 3.1 D).  
 
4.2.2 Proliferation rate of bEnd5 cells 
 
The quantity of GSH in a single bEnd5 cell was estimated by calculating the average 
amount of GSH in a specific number of cells cultured under standard culture 
conditions and dividing the estimated amount of GSH by the number of cells in 
culture. The bEnd5 cells, being adherent cells, needed to be cultured under standard 
conditions and allowed to attach in culture to closely mimic their basal status in the 
BBB at the time of estimation of their GSH content. However, these cells while 
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attaching also multiply thereby challenging our determination of cell number at the 
time of estimation of GSH contents.  
These challenges were addressed by performing a proliferation assay to determine 
the rate of proliferation of bEnd5 cells in culture over the period of hours covering 
our time of estimation. Cell numbers were counted and rate of proliferation studied 
over 35 hours. Cultured bEnd5 cell numbers were found to double at approximately 
16 hours within the first 24 hours and 11 hours within the second 24 hours which 
indicate an increased, but constant rate of proliferation in the second 24 hours.  
The graph of cell numbers plotted against duration of cultures revealed two 
different rates of growth before and after 24 hour (Fig. 3.3), with the slope of the 
growth curve assuming an overtly steeper slope from 24 hour and beyond which is 
an evidence in support of an increased growth rate. The increased rate of growth 
with advancing duration of culture is suggestive of paracrine stimulation of growth 
by contiguous cells now in close contact. The more the number of cells in culture 
at a time, the faster their rate of proliferation appears to be a valid rule for the bEnd5 
cells. This important finding is being reported for the first time for any BEC model 
in the scientific literature. 
  
4.2.3 Estimation of glutathione content of bEnd5 cell line 
 
We estimated the quantity of GSH and GSSG in 1x104 bEnd5 cells using the GSH-
Glo Assay Kit method and the modified GSH recycling method of Tietze, 
respectively (Tietze, 1969). The data allowed for the calculation and extrapolation 
of the cellular GSH content which averaged 0.031±0.00035 nmol.cell-1 (31±0.35 
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pmol.Cell-1) while that of glutathione disulfide (GSSG) amounted to 
0.00092±0.00021 nmol.cell-1 (0.92±0.21 pmol.cell-1) in bEnd5 cells. This puts the 
resting redox status of bEnd5 cells at a percentage GSH:GSSG ratio of 
approximately 97:3.  
Aggressive cancer cells have been reported to contain a relatively higher quantity 
of GSH than normal cells which correlates with their resistance to oxidative 
chemotherapeutic agents (Lash, Putt, & Jankovich, 2015). Indeed the intracellular 
thiol redox state which depends on the GSH content has been noted to be an 
important effector in regulating the mitochondrial permeability transition pore 
complex, which makes thiol oxidation a potential causal factor for a mitochondrial-
based mechanism for cell death (Ortega et al., 2011).  
The content of GSH in bEnd5 cells is relatively higher when compared with values 
obtained in certain cancer cells which are reported to contain high GSH levels. For 
example, HepG2 human liver cancer cells have GSH concentrations of 0.00299 
pmol.cell-1 (Yuan et al., 2013), while the ME180 cell-line (epithelial cells of human 
cervical carcinoma origin) have a GSH level of 0.017 pmol.cell-1 (Lee et al., 1988).  
Given the correlation of elevated GSH levels in various types of neoplastic tissues 
to increased resistance of these tissues to oxidative chemotherapy, a comparatively 
higher GSH content as found in the bEnd5 cells, position BECs for increased 
protection against ROS. This is not unexpected given that the BBB is regularly 
exposed to OS from various sources such as inflammation/pro-inflammatory 
cytokines, amyloid deposits as occur in the ageing process and Alzheimer’s disease, 
excessive alcohol consumption and hypoxic states.  
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Earlier cellular GSH estimation methods reported cellular GSH in the range of 230-
440 nmol.cell-1 for normal human erythrocytes which were much higher than the 
levels obtained in this study. Cellular GSH values reported in human erythrocytes 
was 440 nmol.cell-1 (Ellman, 1959), 230 nmol.cell-1 (Hardin et al., 1954), and 240 
nmol.cell-1 (Tietze, 1969). We suggest that the current values are more accurate 
given the recent advances in the methods of estimation. 
 
4.2.4 Effects of proliferation over 96 hours on the GSH:GSSG profile 
 
The quantity of GSH and GSSG in 1x103 bEnd5 cells was measured over 96 hours 
using the GSH-Glo Assay Kit method and the modified GSH recycling method of 
Tietze, respectively (Tietze, 1969). A considerable amount of energy in the form of 
ATP is required for the process of cell division (Lu, 2009), and therefore, cultured 
cells which are actively dividing are expected to produce high levels of OS 
(Ashtiani et al., 2013).  
Data from our experiments showed that cells under OS had a much higher ratio of 
GSH:GSSG with GSSG levels of 10% to 30%, under stress of 50-500 µM H2O2 
(Fig 3.9 and 3.13). Thus, it was surprising to find that over a period of 96 hours, the 
cell’s GSH:GSSG ratio was fairly stable compared to control group cells (non-H2O2 
stressed group) throughout the 96 hours of culture. GSH depletion has been 
scientifically reported to cause impairment of cellular proliferation in fibroblasts 
(Markovic et al., 2009). Our data indicated that dividing cells endogenous 
antioxidants must be up-regulated during the proliferation of bEnd5 cells, therefore, 
no significant OS is generated during proliferation of bEnd5 cells. 
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4.3 ROS neutralising capacity of bEnd5 cell line at 24 and 48 hours 
 
When the bEnd5 cell line in culture was exposed for 24 and 48 hours to varying 
concentrations of H2O2, ranging from 50 µM to 5 mM, we observed that starting at 
50 µM, there was a switch-like resetting of the GSHT content of the cells to a 
maximum value of about 37% above the basal value. This increment remained 
sustained through until 500 µM, and then dropped rapidly at higher doses of H2O2.  
At 150 µM H2O2, the GSHT peaked at about 37% above resting cellular content and 
without a significant difference from values obtained at other H2O2 concentrations 
between 50 µM and 500 µM. This appears to be the maximum capacity of the 
bEnd5 cells for GSH synthesis and has not been reported in scientific literature 
previously.  
However, between 50 µM and 500 µM H2O2, the increments in the value of the 
GSHT varied within the range of 26.5-37% above resting intracellular content. This 
persistent indifference in the increased amount implies a definite switch in the 
transcriptional control of GSH biosynthesis sensitive to low concentrations of 
reactive oxygen species.  
The maximum increase in the GSH level was at 150 µM H2O2 beyond which a slight 
but significant reduction was seen until 500 µM. At the same concentrations, the 
levels of GSSG showed a slight but steady increase. The GSH:GSSG ratio in the 
control group which was initially approximately 95:5 varied between the 50-500 
µM H2O2 in the range of 90:10 to 85:15 which implied a minimal change in the 
thiol redox status of the bEnd5 cells at treatment concentrations of 50-500 µM H2O2 
(Fig 3.7 and 3.8).  
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Regulation of the thiol redox status of the cell depends largely on the de novo 
synthesis of GSH, the rate of which is governed by the activity of the GCL enzyme. 
Our findings suggest that the bEnd5 cell reacts to slight oxidative challenges by 
switching to its maximal capacity for GSH synthesis and maintaining such until the 
demand for GSH oxidation exceeds its capacity for synthesis. At H2O2 
concentrations above 500 µM, the values of GSHT fell rapidly and there was a rapid 
decrease in the GSH:GSSG ratio until the concentration of the GSSG fraction 
approximately equalled or exceeded that of the GSH (Fig 3.7 and 3.8).  
Scientific evidence supports the existence of plasma membrane transporters for the 
export of GSSG (Ballatori, Krance, Marchan, & Hammond, 2009; Brechbuhl et al., 
2010; Leier et al., 1996). The decrease in the values of GSHT observed at higher 
H2O2 concentrations appears to be attributable to GSSG export as well as the 
decrease in the total number of cells because of ROS-induced cell death 
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Figure 4.1: H2O2 diffuse across cell membranes, which regulates directly or indirectly a 
number of transcription factors, especially Nrf2. Nrf2 under OS becomes activated and 
translocated from the cytoplasm to the nucleus subsequently activating the transcription of 
antioxidant genes which up-regulate L-cysteine transport and glutathione biosynthesis that 
increase GSH levels. GSH is able to convert H2O2 to H2O and O2 in the presence of GSH 
peroxidase. In the process, GSH is oxidised to GSSG, which is either reduced back to GSH 
by GSH reductase at the expense of NADPH, forming a redox cycle, or excretion from the 
cell by ATP-dependent, multidrug resistance protein-related GSSG transporter (Ballatori 
et al., 2009; Brechbuhl et al., 2010; Leier et al., 1996). 
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4.4 Effects of H2O2 on cell growth  
 
Observations of the changes in cell growth support those of a well-maintained thiol 
redox status for the cells between H2O2 concentrations of 50-500 µM. Cell growth 
apparently appeared normal concerning the control group of cells until H2O2 
concentrations exceeded 500 µM. These results were similar for the 24 and 48 hour 
studies. The bEnd5 cells remained well adherent with well-spread cytoplasmic 
extensions. The maintenance of cell shape depends largely on cell cytoskeleton, and 
cell-cell adhesion in the BBB and these characteristics of the brain endothelial cell 
is crucial to the regulation of BBB permeability (Lum & Malik, 1994).  
Specifically, actin cytoskeleton has been reported to be a target for oxidative stress 
which acts by remodelling of the actin filament network with consequent loss of 
cell shape and cell rounding (Lum & Roebuck, 2001). The observations in this study 
underscored the pivoting dynamics of the de novo GSH synthesis and GSSG 
recycling mechanism in regulating GSH homeostasis during the oxidative challenge 
to keep the cell at redox equilibrium.  
However, it was assumed the cells were viable at these concentrations based on the 
intact morphological features observed. At H2O2 concentrations of 1 mM and above 
for 24 and 48 hours, GSHT values fall sharply to a new level about 65% of the 
resting value and remain so at all concentrations of H2O2 above 1.2 mM. The redox 
status of the cell viewed as the GSH:GSSG ratio changed to 1:1 at 1.2 mM H2O2 
concentration. At H2O2 values above 1000 µM, cells decreased in size and were 
fewer in number. 
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4.5 Effects of H2O2 and Trolox on cell growth and GSHT/GSSG/GSH levels 
 
Combined treatment with the antioxidant, Trolox ((±)-6-Hydroxy-2, 5, 7, 8-tetram-
ethylchromane-2-carboxylic acid), and H2O2 produced similar results with respect 
to the cellular GSH content. However, while Trolox does not ameliorate the cellular 
depletion of GSH (Fig 3.15), it protected the cell growth at a concentration of H2O2 
up until 1 mM.  
Cells treated with 25 µM Trolox showed intact growth up to 1 mM H2O2 which 
implies a level of protection is provided by the antioxidant properties of Trolox, a 
water-soluble analog of vitamin E. However, this concentration of Trolox 25 µM 
had no effect on the cellular GSH:GSSG content suggesting that it provides 
protection against ROS using a mechanism which are independent of glutathione 
mechanisms. The signal for the decrease in cell growth is apparently maximal at 
H2O2 concentrations of about 1 mM and higher in the absence of Trolox. In the 
presence of Trolox 25 µM the signal for the decrease in cell growth is averted and 
extended to 1 mM H2O2.  
This signal for decrease in the cell growth is averted with antioxidant treatment but 
above ROS of 1 mM H2O2 cell death will ensue with or without antioxidant 
supplementation 25 µM Trolox. Therefore, it follows that GSH not only is 
important for cellular anti-oxidation but more importantly as a signal transducer for 
cell survival or death. This is exemplified by findings of elevated GSH levels in 
neoplasms that are resistant to oxidative chemotherapeutic drugs (Traverso et al., 
2013).  
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4.6 GSH unassailable at high OS levels  
 
Approximately 32% of resting cellular GSH remained unassailable within the cell 
(Fig 3.7 and 3.12). The utilisation of GSH in the presence of H2O2 challenge 
depends mainly on the availability and activity of the Gpx enzyme (Fig 3.6). This 
unreachable GSH reserve could be because of the limitation in the amount of 
cellular Gpx available to the cell in the presence of such levels of ROS. Whether 
such latent GSH reserve exists is not clearly known, in the in vivo situation. If it 
does exist, this implies any cellular manipulation directed at the upregulation of the 
Gpx enzyme will increase cellular antioxidant capacity by making latent GSH 
reserve available to neutralise more ROS. Furthermore, an antioxidant that supports 
the cellular capacity for increased GSH biosynthesis, such as N-acetyl-L-cysteine 
(NAC) would probably help protect the integrity of the endothelial cells of the BBB 
in situations of severe OS (metabolic pathways of Gpx in Fig 4.1). 
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CHAPTER FIVE 
 
5.1 Conclusion 
 
The BBB insulates the brain from the plasma with its specialised endothelial 
structure that forms the microvasculature of the brain, prohibiting the entry of 
harmful blood-borne substances into the brain microenvironment. Thus, the 
transport of substances in and out of the brain is regulated, as is homeostasis. 
Therefore, understanding the function of the endothelial cells of the brain is of the 
utmost importance. 
 
5.1.1 The presence of GSH in all bEnd5 cells 
 
In this study, it was established that GSH is present in bEnd5 cells and distributed 
throughout the cytoplasm including the nuclear compartment. Variable 
fluorescence intensity observed in the cells indicated that bEnd5 cells have variable 
intracellular concentrations of GSH. The high localisation of GSH at the level of 
the nuclear membrane is indicative of the important role it plays in protecting DNA 
from OS. 
 
5.1.2 Rat-tail collagen and bEnd5 cells attachment  
 
Our technique studied endorsed the methodology that slides coated with rat-tail 
collagen facilitate bEnd5 cell attachment to the slides.  
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5.1.3 Proliferation rate of bEnd5 cells 
 
The growth of cultured bEnd5 cells increases after 24 hours: cultured bEnd5 cell 
numbers were found to double at approximately 15.66 hours within the first 24 
hours and 11 hours within the second 24 hours. This established that cells growing 
in close proximity to each other undergo accelerated cell division.  
 
5.1.4 Estimation of glutathione content of bEnd5 cell line 
 
For the first time, BEC were profiled in terms of their GSHT/GSH/GSSG 
concentration: 
- We established that the average amount of cellular GSH content is 
0.031±0.00035 nmol.cell-1 (31±0.35 pmol.Cell-1), while GSSG amounted to 
0.00092±0.00021 nmol.cell-1 (0.92±0.21 pmol.cell-1) in the bEnd5 cell line. 
- The GSH:GSSG ratio at resting redox status of bEnd5 cells was found to be 
approximately 97:3 at 24 hours in culture. 
- Cultured bEnd5 cells’ basal redox status given as the GSH:GSSG ratio 
ranged from 94:6 to 97:3 over an extended cell culture period of 24-96 
hours. These experiments established that cell growth under culture 
conditions did not produce excess ROS throughout the passage of 96 hours.   
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5.1.5 ROS neutralising capacity of bEnd5 cell line 
 
- When comparing the concentration of GSH per cell to other cell lines, it was 
found that bEnd5 cells contain a relatively greater amount of GSH per cell, 
which indicates the enhanced capability of BEC to neutralise more ROS 
compared to several other varieties of cells. 
- The GSH fraction of glutathione represents more than 95% of the total 
resting pool which confers a very stable resting redox status to these cells. 
The natural ROS neutralising capacity of bEnd5 cells is equivalent to 500 
µMol H2O2, and further increases in OS is not able to deplete the cells of 
GSH before cellular compromise, leaving a level of GSH which appears 
inaccessible in cultured cells at the high level of OS. 
- The redox status of the cell viewed as the GSH:GSSG ratio changed from 
97:3 (GSH:GSSG) to 1:1 at 1.4 mM H2O2 concentration. In future, the 
GSH:GSSG profiling will allow for the level of OS to be monitored in 
cultured cells, and understood as to how it triggers necrosis or apoptosis. 
- Combined treatment with antioxidant, Trolox and H2O2 produced similar 
results to treatment with H2O2 only, with respect to the cellular GSH:GSSG 
ratio and concentration.  
- Trolox does not ameliorate the cellular level of GSH nor does it change the 
GSHT/GSH/GSSG profile of cells under various stages of OS. 
- Trolox did not affect cellular GSH/GSSG content suggesting that it provides 
protection against ROS using a mechanism which is independent of 
glutathione mechanisms.  
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- In conclusion, GSH not only acts in its capacity as an antioxidant but as the 
key signal transducer for cellular survival or death. 
 
5.2 Future studies   
 
Since the following issues were beyond the scope of this study, it is suggested to 
investigate 
• the effect of a higher dose of the protective effect of the exogenous AO 
NAC which will prove cysteine as a substrate for GSH and therefore protect 
against H2O2 toxicity and GSH depletion; 
• whether the inaccessible level of GSH (at high H2O2/SO) was because of 
the cell not having sufficient substrate to form additional GSH.  
In future studies the higher doses of Trolox on conferring greater levels of 
protection to a cell exposed to a high level of OS.  
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APPENDIX A 
 
Table 1. Series concentration of H2O2 (0.05-5 mM) was prepared for the ROS 
neutralising capacity of bEnd5 cells by marking 12 conical tubes A-L. The stock 
solution was diluted as follows to make a series concentration of H2O2 in the table 
below: 
Tube H2O2 stock  
solution (µl) 
Media (ml) Concentration 
(mM) 
A 0 32ml Ctrl 
B 25.5 49.975 5 
C 9000 9 2.5 
D 7200 10.8 2 
I 5400 12.6 1.5 
F 3600 14.4 1 
G 1800  16.2 0.5 
H 500 17.5 0.25 
I 750 17.28 0.2 
J 240 17.76 0.15 
K 360 17.64 0.1 
L 180 17.82 0.05 
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APPENDIX B 
 
Table 2. Effect of exposure to selected concentrations of H2O2 (50 -2500 µM) on 
the GSHT, GSH and GSSG levels in  bEnd5 cells by using the GSH-Glo Assay 
Kit method and the modified GSH recycling method of Tietze respectively 
(Tietze, 1969) at selected time intervals (24 hours) (mean±SEM; n=4). 
 
H2O2 
concentrations 
in µM 
 
GSHT GSH GSSG 
Ctrl 1028619±3828.5 971323±24885.5 57296.0±23914. 
 
50 1368827±20967 1228695±9985 140132±30452 
150 1406145±18925 1215764±28793.5 190381.5±39718.5 
250 1337500±17940 1130065±29075 207435±8935 
500 1276680±18719.5 1087735±30535 188944.5± 49254.5 
1500 662193±14000 327243±43590 334950±36590 
2500 634640±3710 300535±5935. 334105±3025 
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Table 3. Effect of exposure to selected concentrations of H2O2 (50 -2500 µM) on 
the GSHT, GSH and GSSG levels in bEnd5 cells by using the GSH-Glo Assay Kit 
method and the modified GSH recycling method of Tietze respectively (Tietze, 
1969) at selected time intervals (48 hours) (mean±SEM; n=4). 
H2O2 
concentrations 
in µM 
 
GSHT GSH GSSG 
Ctrl 1142251±30358 1183658±100760 
  
50 1826510±99960 1644086±99914 182424±4666 
150 1993515±193988 1471091±101100 522424.5±92888 
250 1964906±204880 1408606±200091 681309±4789 
500 1757661±210285 1231263±199895 526398± 41010 
1500 722286±199584 368366±70004 353920±26988 
2500 722031±101199 370546.5±100172 351484.5±20171 
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APPENDIX C 
Table 4. Combination of 25 µM Trolox and increasing concentrations of H2O2 (50-
5000 µM) was prepared for the protective effect of Trolox against H2O2 toxicity 
and GSH depletion in bEnd5 cells was prepared. the first 1 mM of Trolox was 
prepared by dissolving 0.0025g in 1 ml of DMSO and then made it up to 10 ml with 
the medium. 1.9 ml of 100 mM H2O2 stocks were prepared by added 19.4µl of H2O2 
stock to 1.881 ml of the medium. 15 ml of 1 mM H2O2 was prepared by added 150µl 
of 100 mM H2O2 to 14,85 ml of the medium. Then 25 µM Trolox and increasing 
concentrations of H2O2 (50-5000 µM) was prepared by marking 11 conical tubes 
A-K tube. The 1 mM H2O2 or 100 mM H2O2 and 1 mM of Trolox stocks solution 
were diluted as follows to make a Combination of 25 µM Trolox and increasing 
concentrations of H2O2 (50-5000 µM) as described in the table below: 
 
 
+ 
Tube H2O2 
concentrations 
( µM) 
 
Medium 
(ml)  
1 mM of 
H2O2    
stock 
solution 
(µl) 
100 mM of 
H2O2        
stock 
solution 
(µl) 
1 mM 
Trolox  
stock 
solution 
(µl) 
A 50 14.8 0.8 - 400 
B 100 14 1.6 - 400 
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C 150 13.2 2.4 - 400 
D 200 12.4 3.2 - 400 
E 250 11.6 4 - 400 
F 500 15.52 - 80 400 
G 1000 15.44 - 160 400 
H 1500 15.36 - 240 400 
I 2000 15.28 - 320 400 
J 2500 15.2 - 400 400 
K 5000 14.8 - 800 400 
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APPENDIX D 
Table 5. Effect of exposure to combination of 25 µM Trolox and increasing 
concentrations of H2O2 (50-2500 µM) against H2O2 toxicity and GSH depletion in 
bEnd5 cells by using the GSH-Glo Assay Kit method and the modified GSH 
recycling method of Tietze respectively (Tietze, 1969). At selected time intervals 
(24 hours) (mean±SEM; n=4). 
 
H2O2 
concentrations 
in µM 
 
GSHT GSH GSSG 
Ctrl 1028619 ± 3528.5 
 
971323±24385 57296±27914 
 
Ctrl T 1026139±11868.5 978791±18800.5 47348±6932 
50 1368827±19967 1228695±9485 140132±29452 
50 T 1331785±53765 1218248±5772 113537±59537 
150 1406145±13925 1215764±23793 190382±37718.5 
150 T 1372835±6675 1214671±70981 158164±7765 
250 1337500±12940 1130065±21075 207435±8135 
250 T 1330443±3797 1151780±29300 178663±33097 
500 1276680±17719.5 1087735±29535 188945±47254.5 
500 T 1257932±5738.5 1076575±24285 181357±30023.5 
1500  662193±10000 334950±43590 327243±33590 
1500T 638287±392.5 303725±33600 334562±44190 
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2500 634640±3410 300535±2125 334105±5535 
2500T 633412±5441.844 308170±17155.840 325242±11714 
 
 
Table 6. Effect of exposure to combination of 25 µM Trolox and increasing 
concentrations of H2O2 (50-2500 µM) against H2O2 toxicity and GSH depletion in 
bEnd5 cells by using the GSH-Glo Assay Kit method and the modified GSH 
recycling method of Tietze respectively (Tietze, 1969). At selected time intervals 
48 hours (mean±SEM; n=4) (Chatterjee, Noack, Possel, Keilhoff, & Wolf, 1999). 
 
H2O2 
concentrations 
in µM 
 
GSHT GSH GSSG 
Ctrl 1183658 ±88449 
 
1142251±92672.6 41407±323.5 
 
Ctrl T 1217255±96425 1153622±90648.5 63634±3450 
50 1815710±154970 1630075±138126 185635±15944 
50 T 1826510±159844 1644086±138126 182424±3420 
150 1993515±49075 1471091± 64959.5  522425±15684.5 
150 T 1993525±120365 1483390±83767.6 510136±5430 
250 1964906±164880 1408606±104146 556301±7760 
250 T 1977610±242790 1417759±103335 559852±2360 
500 1757661±150286 1231263±10959 526398±5420 
500 T 1746176±150505 1220244±15505 525933±5430 
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1500  722286±47066. 353920± 3402 368366±6870 
1500T 710195±45299 340894±12326.5 369302±7050 
2500 722031±49801 351485±6522 370547±6820 
2500T 713154±46824 343634±13185.5 369521±3440 
 
 
 
 
 
 
 
